,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,283440,6,4,,103512718,492405,Active,,,4.5,EC50,Inhibition of influenza A virus (A/duck/Minnesota/1525/1981 (H5N1)) replication in MDCK cells by neutral red uptake assay,Confirmatory,17194832.0,
1,283441,7,1,,103512718,492405,Active,,,,,Inhibition of influenza A virus (A/duck/Minnesota/1525/1981 (H5N1)) replication in MDCK cells by virus yield reduction assay,Other,17194832.0,
2,283442,6,4,,103512718,492405,Active,,,11.5,EC50,Inhibition of Influenza A virus (A/gull/Pennsylvania/4175/83 (H5N1)) replication in MDCK cells by neutral red uptake assay,Confirmatory,17194832.0,
3,283443,7,1,,103512718,492405,Active,,,,,Inhibition of Influenza A virus (A/gull/Pennsylvania/4175/83 (H5N1)) replication in MDCK cells by virus yield reduction assay,Other,17194832.0,
4,283444,6,2,,103512718,492405,Active,,,2.6,EC50,Inhibition of viral replication of influenza A virus (A/Hong Kong/213/03(H5N1)) and influenza A virus (A/Ann Arbor/6/60(H2N2)) hybrid virus in MDCK cells by neutral red uptake assay,Confirmatory,17194832.0,
5,283445,7,1,,103512718,492405,Active,,,,,Inhibition of viral replication of influenza A virus (A/Hong Kong/213/03(H5N1)) and influenza A virus (A/Ann Arbor/6/60(H2N2)) hybrid virus in MDCK cells by virus yield reduction assay,Other,17194832.0,
6,283446,6,2,,103512718,492405,Active,,,12.1,EC50,Inhibition of viral replication of influenza A virus (A/Vietnam/1203/2004 (H5N1)) and influenza A virus (A/Ann Arbor/6/60(H2N2)) hybrid virus in MDCK cells by neutral red uptake assay,Confirmatory,17194832.0,
7,283447,7,1,,103512718,492405,Active,,,,,Inhibition of viral replication of influenza A virus (A/Vietnam/1203/2004 (H5N1)) and influenza A virus (A/Ann Arbor/6/60(H2N2)) hybrid virus in MDCK cells by virus yield reduction assay,Other,17194832.0,
8,283448,6,2,,103512718,492405,Unspecified,,,641.0,CC50,Cytotoxicity against MDCK cells,Confirmatory,17194832.0,
9,283449,3,3,,103512718,492405,Active,,,,,"Effect on survival of BALB/c mouse infected with influenza A virus (A/duck/Minnesota/1525/1981 (H5N1)) at 300 mg/kg/day, po qid for 5 days administered 1 hr after infection relative to carboxymethyl cellulose",Other,17194832.0,
10,283450,3,3,,103512718,492405,Active,,,,,"Effect on survival of BALB/c mouse infected with influenza A virus (A/duck/Minnesota/1525/1981 (H5N1)) at 100 mg/kg/day, po qid for 5 days administered 1 hr after infection relative to carboxymethyl cellulose",Other,17194832.0,
11,283451,3,3,,103512718,492405,Active,,,,,"Effect on survival of BALB/c mouse infected with influenza A virus (A/duck/Minnesota/1525/1981 (H5N1)) at 33 mg/kg/day, po qid for 5 days administered 1 hr after infection relative to carboxymethyl cellulose",Other,17194832.0,
12,283452,3,5,,103512718,492405,Unspecified,,,,,"Reduction of lung viral titre in BALB/c mouse infected with influenza A virus (A/duck/Minnesota/1525/1981 (H5N1)) at 300 mg/kg/day, po qid for 5 days administered 1 hr after infection measured on day 1 relative to carboxymethyl cellulose",Other,17194832.0,
13,283453,3,5,,103512718,492405,Unspecified,,,,,"Reduction of lung viral titre in BALB/c mouse infected with influenza A virus (A/duck/Minnesota/1525/1981 (H5N1)) at 100 mg/kg/day, po qid for 5 days administered 1 hr after infection measured on day 1 relative to carboxymethyl cellulose",Other,17194832.0,
14,283454,3,5,,103512718,492405,Unspecified,,,,,"Reduction of lung viral titre in BALB/c mouse infected with influenza A virus (A/duck/Minnesota/1525/1981 (H5N1)) at 33 mg/kg/day, po qid for 5 days administered 1 hr after infection measured on day 1 relative to carboxymethyl cellulose",Other,17194832.0,
15,283456,3,3,,103512718,492405,Unspecified,,,,,"Inhibition of increase in lung weight of BALB/c mouse infected with influenza A virus (A/duck/Minnesota/1525/1981 (H5N1)) at 300 mg/kg/day, po qid for 5 days administered 1 hr after infection measured on day 6 relative to carboxymethyl cellulose",Other,17194832.0,
16,283457,3,3,,103512718,492405,Unspecified,,,,,"Inhibition of increase in lung weight of BALB/c mouse infected with influenza A virus (A/duck/Minnesota/1525/1981 (H5N1)) at 100 mg/kg/day, po qid for 5 days administered 1 hr after infection measured on day 6 relative to carboxymethyl cellulose",Other,17194832.0,
17,283458,3,3,,103512718,492405,Unspecified,,,,,"Inhibition of increase in lung weight of BALB/c mouse infected with influenza A virus (A/duck/Minnesota/1525/1981 (H5N1)) at 33 mg/kg/day, po qid for 5 days administered 1 hr after infection measured on day 6 relative to carboxymethyl cellulose",Other,17194832.0,
18,283460,3,3,,103512718,492405,Unspecified,,,,,"Lowering of Arterial oxygen saturation decline in BALB/c mouse infected with influenza A virus (A/duck/Minnesota/1525/1981 (H5N1)) at 300 mg/kg/day, po qid for 5 days administered 1 hr after infection measured on day 11 relative to carboxymethyl cellulose",Other,17194832.0,
19,283461,3,3,,103512718,492405,Unspecified,,,,,"Lowering of Arterial oxygen saturation decline in BALB/c mouse infected with influenza A virus (A/duck/Minnesota/1525/1981 (H5N1)) at 100 mg/kg/day, po qid for 5 days administered 1 hr after infection measured on day 11 relative to carboxymethyl cellulose",Other,17194832.0,
20,283462,3,3,,103512718,492405,Unspecified,,,,,"Lowering of Arterial oxygen saturation decline in BALB/c mouse infected with influenza A virus (A/duck/Minnesota/1525/1981 (H5N1)) at 33 mg/kg/day, po qid for 5 days administered 1 hr after infection measured on day 11 relative to carboxymethyl cellulose",Other,17194832.0,
21,283464,3,3,,103512718,492405,Unspecified,,,,,"Toxicity in BALB/c mouse assessed as survival at 300 mg/kg/day, po qid for 5 days",Other,17194832.0,
22,283465,3,3,,103512718,492405,Unspecified,,,,,"Toxicity in BALB/c mouse assessed as survival at 100 mg/kg/day, po qid for 5 days",Other,17194832.0,
23,283466,3,3,,103512718,492405,Unspecified,,,,,"Toxicity in BALB/c mouse assessed as survival at 33 mg/kg/day, po qid for 5 days",Other,17194832.0,
24,283468,3,3,,103512718,492405,Unspecified,,,,,"Effect on weight change in BALB/c mouse at 300 mg/kg/day, po qid measured after 18 hrs of final treatment",Other,17194832.0,
25,283469,3,3,,103512718,492405,Unspecified,,,,,"Effect on weight change in BALB/c mouse at 100 mg/kg/day, po qid measured after 18 hrs of final treatment",Other,17194832.0,
26,283470,3,3,,103512718,492405,Unspecified,,,,,"Effect on weight change in BALB/c mouse at 33 mg/kg/day, po qid measured after 18 hrs of final treatment",Other,17194832.0,
27,283472,3,3,,103512718,492405,Unspecified,,,,,"Toxicity in BALB/c mouse assessed as survival at 300 mg/kg/day, po once daily",Other,17194832.0,
28,283473,3,3,,103512718,492405,Unspecified,,,,,"Toxicity in BALB/c mouse assessed as survival at 100 mg/kg/day, po once daily",Other,17194832.0,
29,283474,3,3,,103512718,492405,Unspecified,,,,,"Toxicity in BALB/c mouse assessed as survival at 30 mg/kg/day, po once daily",Other,17194832.0,
30,283475,3,3,,103512718,492405,Unspecified,,,,,"Toxicity in BALB/c mouse assessed as survival at 10 mg/kg/day, po once daily",Other,17194832.0,
31,283476,3,3,,103512718,492405,Unspecified,,,,,"Toxicity in BALB/c mouse assessed as survival at 3 mg/kg/day, po once daily",Other,17194832.0,
32,283477,3,3,,103512718,492405,Unspecified,,,,,"Effect on weight change in BALB/c mouse at 300 mg/kg/day, po once daily for 5 days measured after 18 hrs of final treatment",Other,17194832.0,
33,283478,3,3,,103512718,492405,Unspecified,,,,,"Effect on weight change in BALB/c mouse at 100 mg/kg/day, po once daily for 5 days measured after 18 hrs of final treatment",Other,17194832.0,
34,283479,3,3,,103512718,492405,Unspecified,,,,,"Effect on weight change in BALB/c mouse at 30 mg/kg/day, po once daily for 5 days measured after 18 hrs of final treatment",Other,17194832.0,
35,283480,3,3,,103512718,492405,Unspecified,,,,,"Effect on weight change in BALB/c mouse at 10 mg/kg/day, po once daily for 5 days measured after 18 hrs of final treatment",Other,17194832.0,
36,283481,3,3,,103512718,492405,Unspecified,,,,,"Effect on weight change in BALB/c mouse at 3 mg/kg/day, po once daily for 5 days measured after 18 hrs of final treatment",Other,17194832.0,
37,283482,3,3,,103512718,492405,Active,,,,,"Effect on survival of BALB/c mouse infected with influenza A virus (A/duck/Minnesota/1525/1981 (H5N1)) at 300 mg/kg/day, po once daily for 5 days administered 1 hr after infection relative to carboxymethyl cellulose",Other,17194832.0,
38,283483,3,3,,103512718,492405,Active,,,,,"Effect on survival of BALB/c mouse infected with influenza A virus (A/duck/Minnesota/1525/1981 (H5N1)) at 100 mg/kg/day, po once daily for 5 days administered 1 hr after infection relative to carboxymethyl cellulose",Other,17194832.0,
39,283484,3,3,,103512718,492405,Inactive,,,,,"Effect on survival of BALB/c mouse infected with influenza A virus (A/duck/Minnesota/1525/1981 (H5N1)) at 3 mg/kg/day, po once daily for 5 days administered 1 hr after infection relative to carboxymethyl cellulose",Other,17194832.0,
40,283485,3,3,,103512718,492405,Unspecified,,,,,"Lowering of arterial oxygen saturation decline in BALB/c mouse infected with influenza A virus (A/duck/Minnesota/1525/1981 (H5N1)) at 300 mg/kg/day, po once daily for 5 days administered 1 hr after infection measured on day 11 relative to carboxymethyl cellulose",Other,17194832.0,
41,283486,3,3,,103512718,492405,Unspecified,,,,,"Lowering of arterial oxygen saturation decline in BALB/c mouse infected with influenza A virus (A/duck/Minnesota/1525/1981 (H5N1)) at 100 mg/kg/day, po once daily for 5 days administered 1 hr after infection measured on day 11 relative to carboxymethyl cellulose",Other,17194832.0,
42,283487,3,3,,103512718,492405,Unspecified,,,,,"Lowering of arterial oxygen saturation decline in BALB/c mouse infected with influenza A virus (A/duck/Minnesota/1525/1981 (H5N1)) at 30 mg/kg/day, po once daily for 5 days administered 1 hr after infection measured on day 11 relative to carboxymethyl cellulose",Other,17194832.0,
43,283488,3,3,,103512718,492405,Unspecified,,,,,"Lowering of arterial oxygen saturation decline in BALB/c mouse infected with influenza A virus (A/duck/Minnesota/1525/1981 (H5N1)) at 10 mg/kg/day, po once daily for 5 days administered 1 hr after infection measured on day 11 relative to carboxymethyl cellulose",Other,17194832.0,
44,283489,3,3,,103512718,492405,Unspecified,,,,,"Lowering of arterial oxygen saturation decline in BALB/c mouse infected with influenza A virus (A/duck/Minnesota/1525/1981 (H5N1)) at 3 mg/kg/day, po once daily for 5 days administered 1 hr after infection measured on day 11 relative to carboxymethyl cellulose",Other,17194832.0,
45,283490,3,3,,103512718,492405,Active,,,,,"Effect on survival of BALB/c mouse infected with influenza A virus (A/duck/Minnesota/1525/1981 (H5N1)) at 300 mg/kg/day, po qid for 5 days administered 24 hrs after infection relative to carboxymethyl cellulose",Other,17194832.0,
46,283491,3,3,,103512718,492405,Active,,,,,"Effect on survival of BALB/c mouse infected with influenza A virus (A/duck/Minnesota/1525/1981 (H5N1)) at 300 mg/kg/day, po qid for 5 days administered 36 hrs after infection relative to carboxymethyl cellulose",Other,17194832.0,
47,283492,3,3,,103512718,492405,Active,,,,,"Effect on survival of BALB/c mouse infected with influenza A virus (A/duck/Minnesota/1525/1981 (H5N1)) at 300 mg/kg/day, po qid for 5 days administered 60 hrs after infection relative to carboxymethyl cellulose",Other,17194832.0,
48,283493,3,3,,103512718,492405,Active,,,,,"Effect on survival of BALB/c mouse infected with influenza A virus (A/duck/Minnesota/1525/1981 (H5N1)) at 300 mg/kg/day, po qid for 5 days administered 84 hrs after infection relative to carboxymethyl cellulose",Other,17194832.0,
49,283494,3,3,,103512718,492405,Unspecified,,,,,"Lowering of arterial oxygen saturation decline in BALB/c mouse infected with influenza A virus (A/duck/Minnesota/1525/1981 (H5N1)) at 300 mg/kg/day, po qid for 5 days administered 24 hrs after infection measured on day 11 relative to carboxymethyl cellulose",Other,17194832.0,
50,283495,3,3,,103512718,492405,Unspecified,,,,,"Lowering of arterial oxygen saturation decline in BALB/c mouse infected with influenza A virus (A/duck/Minnesota/1525/1981 (H5N1)) at 300 mg/kg/day, po qid for 5 days administered 36 hrs after infection measured on day 11 relative to carboxymethyl cellulose",Other,17194832.0,
51,283496,3,3,,103512718,492405,Unspecified,,,,,"Lowering of arterial oxygen saturation decline in BALB/c mouse infected with influenza A virus (A/duck/Minnesota/1525/1981 (H5N1)) at 300 mg/kg/day, po qid for 5 days administered 48 hrs after infection measured on day 11 relative to carboxymethyl cellulose",Other,17194832.0,
52,283497,3,3,,103512718,492405,Unspecified,,,,,"Lowering of arterial oxygen saturation decline in BALB/c mouse infected with influenza A virus (A/duck/Minnesota/1525/1981 (H5N1)) at 300 mg/kg/day, po qid for 5 days administered 60 hrs after infection measured on day 11 relative to carboxymethyl cellulose",Other,17194832.0,
53,283498,3,3,,103512718,492405,Unspecified,,,,,"Lowering of arterial oxygen saturation decline in BALB/c mouse infected with influenza A virus (A/duck/Minnesota/1525/1981 (H5N1)) at 300 mg/kg/day, po qid for 5 days administered 72 hrs after infection measured on day 11 relative to carboxymethyl cellulose",Other,17194832.0,
54,283499,3,3,,103512718,492405,Unspecified,,,,,"Lowering of arterial oxygen saturation decline in BALB/c mouse infected with influenza A virus (A/duck/Minnesota/1525/1981 (H5N1)) at 300 mg/kg/day, po qid for 5 days administered 84 hrs after infection measured on day 11 relative to carboxymethyl cellulose",Other,17194832.0,
55,283500,3,3,,103512718,492405,Unspecified,,,,,"Lowering of arterial oxygen saturation decline in BALB/c mouse infected with influenza A virus (A/duck/Minnesota/1525/1981 (H5N1)) at 300 mg/kg/day, po qid for 5 days administered 96 hrs after infection measured on day 11 relative to carboxymethyl cellulose",Other,17194832.0,
56,283501,3,3,,103512718,492405,Unspecified,,,,,"Lowering of arterial oxygen saturation decline in BALB/c mouse infected with influenza A virus (A/duck/Minnesota/1525/1981 (H5N1)) at 300 mg/kg/day, po qid for 5 days administered 120 hrs after infection measured on day 11 relative to carboxymethyl cellulose",Other,17194832.0,
57,283502,3,3,,103512718,492405,Active,,,,,"Effect on survival in BALB/c mouse infected with influenza A virus (A/duck/Minnesota/1525/1981 (H5N1)) at 300 mg/kg/day, po administered 4 hrs after infection relative to carboxymethyl cellulose",Other,17194832.0,
58,283503,3,3,,103512718,492405,Active,,,,,"Effect on survival in BALB/c mouse infected with influenza A virus (A/duck/Minnesota/1525/1981 (H5N1)) at 600 mg/kg/day, po administered 4 hrs after infection relative to carboxymethyl cellulose",Other,17194832.0,
59,283504,3,3,,103512718,492405,Active,,,,,"Effect on survival in BALB/c mouse infected with influenza A virus (A/duck/Minnesota/1525/1981 (H5N1)) at 300 mg/kg/day, po administered 12 hrs after infection relative to carboxymethyl cellulose",Other,17194832.0,
60,283505,3,3,,103512718,492405,Active,,,,,"Effect on survival in BALB/c mouse infected with influenza A virus (A/duck/Minnesota/1525/1981 (H5N1)) at 600 mg/kg/day, po administered 12 hrs after infection relative to carboxymethyl cellulose",Other,17194832.0,
61,283506,3,3,,103512718,492405,Active,,,,,"Effect on survival in BALB/c mouse infected with influenza A virus (A/duck/Minnesota/1525/1981 (H5N1)) at 300 mg/kg/day, po administered 24 hrs after infection relative to carboxymethyl cellulose",Other,17194832.0,
62,283507,3,3,,103512718,492405,Active,,,,,"Effect on survival in BALB/c mouse infected with influenza A virus (A/duck/Minnesota/1525/1981 (H5N1)) at 600 mg/kg/day, po administered 24 hrs after infection relative to carboxymethyl cellulose",Other,17194832.0,
63,283508,3,3,,103512718,492405,Active,,,,,"Effect on survival in BALB/c mouse infected with influenza A virus (A/duck/Minnesota/1525/1981 (H5N1)) at 300 mg/kg/day, po administered 48 hrs after infection relative to carboxymethyl cellulose",Other,17194832.0,
64,283509,3,3,,103512718,492405,Active,,,,,"Effect on survival in BALB/c mouse infected with influenza A virus (A/duck/Minnesota/1525/1981 (H5N1)) at 600 mg/kg/day, po administered 48 hrs after infection relative to carboxymethyl cellulose",Other,17194832.0,
65,283510,3,3,,103512718,492405,Active,,,,,"Effect on survival in BALB/c mouse infected with influenza A virus (A/duck/Minnesota/1525/1981 (H5N1)) at 600 mg/kg/day, po administered 60 hrs after infection relative to carboxymethyl cellulose",Other,17194832.0,
66,283511,3,3,,103512718,492405,Unspecified,,,,,"Toxicity in BALB/c mouse assessed as survival at 300 mg/kg/day, po twice daily",Other,17194832.0,
67,283512,3,3,,103512718,492405,Unspecified,,,,,"Toxicity in BALB/c mouse assessed as survival at 100 mg/kg/day, po twice daily",Other,17194832.0,
68,283513,3,3,,103512718,492405,Unspecified,,,,,"Toxicity in BALB/c mouse assessed as survival at 30 mg/kg/day, po twice daily",Other,17194832.0,
69,283514,3,3,,103512718,492405,Unspecified,,,,,"Toxicity in BALB/c mouse assessed as survival at 10 mg/kg/day, po twice daily",Other,17194832.0,
70,283515,3,3,,103512718,492405,Unspecified,,,,,"Toxicity in BALB/c mouse assessed as survival at 3 mg/kg/day, po twice daily",Other,17194832.0,
71,283516,3,3,,103512718,492405,Unspecified,,,,,"Effect on weight change in BALB/c mouse at 300 mg/kg/day, po twice daily for 5 days measured after 18 hrs of final treatment",Other,17194832.0,
72,283517,3,3,,103512718,492405,Unspecified,,,,,"Effect on weight change in BALB/c mouse at 100 mg/kg/day, po twice daily for 5 days measured after 18 hrs of final treatment",Other,17194832.0,
73,283518,3,3,,103512718,492405,Unspecified,,,,,"Effect on weight change in BALB/c mouse at 30 mg/kg/day, po twice daily for 5 days measured after 18 hrs of final treatment",Other,17194832.0,
74,283519,3,3,,103512718,492405,Unspecified,,,,,"Effect on weight change in BALB/c mouse at 10 mg/kg/day, po twice daily for 5 days measured after 18 hrs of final treatment",Other,17194832.0,
75,283520,3,3,,103512718,492405,Unspecified,,,,,"Effect on weight change in BALB/c mouse at 3 mg/kg/day, po twice daily for 5 days measured after 18 hrs of final treatment",Other,17194832.0,
76,283521,3,3,,103512718,492405,Active,,,,,"Effect on survival of BALB/c mouse infected with influenza A virus (A/duck/Minnesota/1525/1981 (H5N1)) at 300 mg/kg/day, po twice daily for 5 days administered 1 hr after infection relative to carboxymethyl cellulose",Other,17194832.0,
77,283522,3,3,,103512718,492405,Active,,,,,"Effect on survival of BALB/c mouse infected with influenza A virus (A/duck/Minnesota/1525/1981 (H5N1)) at 100 mg/kg/day, po twice daily for 5 days administered 1 hr after infection relative to carboxymethyl cellulose",Other,17194832.0,
78,283523,3,3,,103512718,492405,Active,,,,,"Effect on survival of BALB/c mouse infected with influenza A virus (A/duck/Minnesota/1525/1981 (H5N1)) at 3 mg/kg/day, po twice daily for 5 days administered 1 hr after infection relative to carboxymethyl cellulose",Other,17194832.0,
79,283524,3,3,,103512718,492405,Unspecified,,,,,"Lowering of Arterial oxygen saturation decline in BALB/c mouse infected with influenza A virus (A/duck/Minnesota/1525/1981 (H5N1)) at 300 mg/kg/day, po twice daily for 5 days administered 1 hr after infection measured on day 11 relative to carboxymethyl cellulose",Other,17194832.0,
80,283525,3,3,,103512718,492405,Unspecified,,,,,"Lowering of Arterial oxygen saturation decline in BALB/c mouse infected with influenza A virus (A/duck/Minnesota/1525/1981 (H5N1)) at 100 mg/kg/day, po twice daily for 5 days administered 1 hr after infection measured on day 11 relative to carboxymethyl cellulose",Other,17194832.0,
81,283526,3,3,,103512718,492405,Unspecified,,,,,"Lowering of Arterial oxygen saturation decline in BALB/c mouse infected with influenza A virus (A/duck/Minnesota/1525/1981 (H5N1)) at 30 mg/kg/day, po twice daily for 5 days administered 1 hr after infection measured on day 11 relative to carboxymethyl cellulose",Other,17194832.0,
82,283527,3,3,,103512718,492405,Unspecified,,,,,"Lowering of Arterial oxygen saturation decline in BALB/c mouse infected with influenza A virus (A/duck/Minnesota/1525/1981 (H5N1)) at 10 mg/kg/day, po twice daily for 5 days administered 1 hr after infection measured on day 11 relative to carboxymethyl cellulose",Other,17194832.0,
83,283528,3,3,,103512718,492405,Unspecified,,,,,"Lowering of Arterial oxygen saturation decline in BALB/c mouse infected with influenza A virus (A/duck/Minnesota/1525/1981 (H5N1)) at 3 mg/kg/day, po twice daily for 5 days administered 1 hr after infection measured on day 11 relative to carboxymethyl cellulose",Other,17194832.0,
84,369460,6,2,,103512718,492405,Unspecified,,,6257.0,CC50,Cytotoxicity against african green monkey Vero 76 cells assessed as cell viability after 3 to 5 days,Confirmatory,17606691.0,
85,369461,6,2,,103512718,492405,Active,,,32.0,EC50,Antiviral activity against La Crosse virus assessed as inhibition of virus-induced visual cytopathic effect after 3 to 5 days,Confirmatory,17606691.0,
86,369462,6,2,,103512718,492405,Unspecified,,,191.0,EC50,Antiviral activity against Punta Toro virus Adames assessed as inhibition of virus-induced visual cytopathic effect after 3 to 5 days,Confirmatory,17606691.0,
87,369463,6,2,,103512718,492405,Active,,,32.0,EC50,Antiviral activity against Rift Valley fever virus MP-12 assessed as inhibition of virus-induced visual cytopathic effect after 3 to 5 days,Confirmatory,17606691.0,
88,369464,6,2,,103512718,492405,Unspecified,,,115.0,EC50,Antiviral activity against Sandfly fever Naples virus assessed as inhibition of virus-induced visual cytopathic effect after 3 to 5 days,Confirmatory,17606691.0,
89,369465,3,4,,103512718,492405,Unspecified,,,,,"Selectivity index, ratio of CC50 for african green monkey Vero 76 cells to EC50 for La Crosse virus",Other,17606691.0,
90,369466,3,4,,103512718,492405,Unspecified,,,,,"Selectivity index, ratio of CC50 for african green monkey Vero 76 cells to EC50 for Punta Toro virus Adames",Other,17606691.0,
91,369467,3,4,,103512718,492405,Unspecified,,,,,"Selectivity index, ratio of CC50 for african green monkey Vero 76 cells to EC50 for Rift Valley fever virus MP-12",Other,17606691.0,
92,369468,3,4,,103512718,492405,Unspecified,,,,,"Selectivity index, ratio of CC50 for african green monkey Vero 76 cells to EC50 for Sandfly fever Naples virus",Other,17606691.0,
93,369469,7,1,,103512718,492405,Active,,,,,Antiviral activity against La Crosse virus assessed as reduction of 1 log10 unit viral titer yields after 3 to 5 days,Other,17606691.0,
94,369470,7,1,,103512718,492405,Active,,,,,Antiviral activity against Punta Toro virus Adames assessed as reduction of 1 log10 unit viral titer yields after 3 to 5 days,Other,17606691.0,
95,369471,7,1,,103512718,492405,Active,,,,,Antiviral activity against Rift Valley fever virus MP-12 assessed as reduction of 1 log10 unit viral titer yields after 3 to 5 days,Other,17606691.0,
96,369472,7,1,,103512718,492405,Active,,,,,Antiviral activity against Sandfly fever Naples virus assessed as reduction of 1 log10 unit viral titer yields after 3 to 5 days,Other,17606691.0,
97,369473,3,3,,103512718,492405,Active,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as survival at 100 mg/kg, po twice daily for 5 days administered 4 hrs before viral challenge",Other,17606691.0,
98,369474,3,3,,103512718,492405,Active,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as survival at 50 mg/kg, po twice daily for 5 days administered 4 hrs before viral challenge",Other,17606691.0,
99,369475,3,3,,103512718,492405,Active,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as survival at 25 mg/kg, po twice daily for 5 days administered 4 hrs before viral challenge",Other,17606691.0,
100,369476,3,3,,103512718,492405,Active,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as survival at 75 mg/kg, po twice daily for 5 days administered 4 hrs before viral challenge",Other,17606691.0,
101,369477,6,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as mean day of death at 200 mg/kg, po twice daily for 5 days administered 4 hrs before viral challenge",Other,17606691.0,
102,369478,6,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as mean day of death at 100 mg/kg, po twice daily for 5 days administered 4 hrs before viral challenge",Other,17606691.0,
103,369839,6,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as mean day of death at 50 mg/kg, po twice daily for 5 days administered 4 hrs before viral challenge",Other,17606691.0,
104,369840,6,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as mean day of death at 25 mg/kg, po twice daily for 5 days administered 4 hrs before viral challenge",Other,17606691.0,
105,369841,6,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as mean day of death at 75 mg/kg, po twice daily for 5 days administered 4 hrs before viral challenge",Other,17606691.0,
106,369842,3,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as mean viral titer per 0.1 g of liver at 200 mg/kg, po twice daily administered 4 hrs before viral challenge measured on day 4 of viral infection",Other,17606691.0,
107,369843,3,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as mean viral titer per 0.1 g of liver at 100 mg/kg, po administered 4 hrs before viral challenge measured on day 4 of viral infection",Other,17606691.0,
108,369844,3,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as mean viral titer per 0.1 g of liver at 50 mg/kg, po administered 4 hrs before viral challenge measured on day 4 of viral infection",Other,17606691.0,
109,369845,3,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as mean viral titer per 0.1 g of liver at 25 mg/kg, po administered 4 hrs before viral challenge measured on day 4 of viral infection",Other,17606691.0,
110,369846,3,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as mean viral titer per 0.1 g of liver at 75 mg/kg, po administered 4 hrs before viral challenge measured on day 4 of viral infection",Other,17606691.0,
111,369847,3,4,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as animals with detectable virus level in liver at 200 mg/kg, po twice daily administered 4 hrs before viral challenge measured on day 4 of viral infection",Other,17606691.0,
112,369848,3,4,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as animals with detectable virus level in liver at 100 mg/kg, po twice daily administered 4 hrs before viral challenge measured on day 4 of viral infection",Other,17606691.0,
113,369849,3,4,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as animals with detectable virus level in liver at 50 mg/kg, po twice daily administered 4 hrs before viral challenge measured on day 4 of viral infection",Other,17606691.0,
114,369850,3,4,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as animals with detectable virus level in liver at 25 mg/kg, po twice daily administered 4 hrs before viral challenge measured on day 4 of viral infection",Other,17606691.0,
115,369851,3,4,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as animals with detectable virus level in liver at 75 mg/kg, po twice daily administered 4 hrs before viral challenge measured on day 4 of viral infection",Other,17606691.0,
116,369852,3,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as mean viral titer per 0.1 mL of serum at 200 mg/kg, po twice daily administered 4 hrs before viral challenge measured on day 4 of viral infection",Other,17606691.0,
117,369853,3,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as mean viral titer per 0.1 mL of serum at 100 mg/kg, po twice daily administered 4 hrs before viral challenge measured on day 4 of viral infection",Other,17606691.0,
118,369854,3,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as mean viral titer per 0.1 mL of serum at 50 mg/kg, po twice daily administered 4 hrs before viral challenge measured on day 4 of viral infection",Other,17606691.0,
119,369855,3,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as mean viral titer per 0.1 mL of serum at 25 mg/kg, po twice daily administered 4 hrs before viral challenge measured on day 4 of viral infection",Other,17606691.0,
120,369856,3,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as mean viral titer per 0.1 mL of serum at 75 mg/kg, po twice daily administered 4 hrs before viral challenge measured on day 4 of viral infection",Other,17606691.0,
121,369857,3,4,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as animals with detectable virus level in serum at 200 mg/kg, po twice daily administered 4 hrs before viral challenge measured on day 4 of viral infection",Other,17606691.0,
122,369858,3,4,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as animals with detectable virus level in serum at 100 mg/kg, po twice daily administered 4 hrs before viral challenge measured on day 4 of viral infection",Other,17606691.0,
123,369859,3,4,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as animals with detectable virus level in serum at 50 mg/kg, po twice daily administered 4 hrs before viral challenge measured on day 4 of viral infection",Other,17606691.0,
124,369860,3,4,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as animals with detectable virus level in serum at 25 mg/kg, po twice daily administered 4 hrs before viral challenge measured on day 4 of viral infection",Other,17606691.0,
125,369863,8,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as mean serum ALT levels at 200 mg/kg, po twice daily administered 4 hrs before viral challenge measured on day 4 of viral infection",Other,17606691.0,
126,369864,8,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as mean serum ALT levels at 100 mg/kg, po twice daily administered 4 hrs before viral challenge measured on day 4 of viral infection",Other,17606691.0,
127,369865,8,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as mean serum ALT levels at 50 mg/kg, po twice daily administered 4 hrs before viral challenge measured on day 4 of viral infection",Other,17606691.0,
128,369866,8,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as mean serum ALT levels at 25 mg/kg, po twice daily administered 4 hrs before viral challenge measured on day 4 of viral infection",Other,17606691.0,
129,369868,3,3,,103512718,492405,Active,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as inhibition of liver damage at 200 mg/kg, po twice daily administered 4 hrs before viral challenge measured on day 4 of viral infection",Other,17606691.0,
130,369869,3,4,,103512718,492405,Unspecified,,,,,"Antiviral activity against 5000 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as animals with detectable virus level in serum at 30 mg/kg, po twice daily administered 24 hrs post viral challenge measured on day 3 of viral infection",Other,17606691.0,
131,369870,8,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against 5000 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as mean serum ALT levels at 30 mg/kg, po twice daily administered 24 hrs post viral challenge measured on day 3 of viral infection",Other,17606691.0,
132,369871,3,4,,103512718,492405,Unspecified,,,,,"Antiviral activity against 5000 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as survival at 30 mg/kg, po twice daily for 5 days 24 hrs post viral challenge",Other,17606691.0,
133,369872,6,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as mean day of death at 30 mg/kg, po twice daily for 5 days administered 4 hrs before viral challenge",Other,17606691.0,
134,369873,6,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as mean day of death at 10 mg/kg, po twice daily for 5 days administered 4 hrs before viral challenge",Other,17606691.0,
135,369874,6,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as mean day of death at 5 mg/kg, po twice daily for 5 days administered 4 hrs before viral challenge",Other,17606691.0,
136,369875,3,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as mean viral titer per 0.1 g of liver at 30 mg/kg, po twice daily administered 4 hrs before viral challenge measured on day 3 of viral infection",Other,17606691.0,
137,369876,3,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as mean viral titer per 0.1 g of liver at 10 mg/kg, po twice daily administered 4 hrs before viral challenge measured on day 3 of viral infection",Other,17606691.0,
138,369877,3,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as mean viral titer per 0.1 g of liver at 5 mg/kg, po twice daily administered 4 hrs before viral challenge measured on day 3 of viral infection",Other,17606691.0,
139,369878,3,4,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as animals with detectable virus level in liver at 30 mg/kg, po twice daily administered 4 hrs before viral challenge measured on day 3 of viral infection",Other,17606691.0,
140,369879,3,4,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as animals with detectable virus level in liver at 10 mg/kg, po twice daily administered 4 hrs before viral challenge measured on day 3 of viral infection",Other,17606691.0,
141,369880,3,4,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as animals with detectable virus level in liver at 5 mg/kg, po twice daily administered 4 hrs before viral challenge measured on day 3 of viral infection",Other,17606691.0,
142,369881,3,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as mean viral titer per 0.1 mL of serum at 30 mg/kg, po twice daily administered 4 hrs before viral challenge measured on day 3 of viral infection",Other,17606691.0,
143,369882,3,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as mean viral titer per 0.1 mL of serum at 10 mg/kg, po twice daily administered 4 hrs before viral challenge measured on day 3 of viral infection",Other,17606691.0,
144,369883,3,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as mean viral titer per 0.1 mL of serum at 5 mg/kg, po twice daily administered 4 hrs before viral challenge measured on day 3 of viral infection",Other,17606691.0,
145,370190,3,4,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as animals with detectable virus level in serum at 30 mg/kg, po twice daily administered 4 hrs before viral challenge measured on day 3 of viral infection",Other,17606691.0,
146,370191,3,4,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as animals with detectable virus level in serum at 10 mg/kg, po twice daily administered 24 hrs post viral challenge measured on day 3 of viral infection",Other,17606691.0,
147,370192,3,4,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as animals with detectable virus level in serum at 5 mg/kg, po twice daily administered 4 hrs before viral challenge measured on day 3 of viral infection",Other,17606691.0,
148,370193,8,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as mean serum ALT levels at 30 mg/kg, po twice daily administered 4 hrs before viral challenge measured on day 3 of viral infection",Other,17606691.0,
149,370194,8,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as mean serum ALT levels at 10 mg/kg, po twice daily administered 4 hrs before viral challenge measured on day 3 of viral infection",Other,17606691.0,
150,370195,8,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as mean serum ALT levels at 5 mg/kg, po twice daily administered 4 hrs before viral challenge measured on day 3 of viral infection",Other,17606691.0,
151,370196,3,3,,103512718,492405,Active,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as inhibition of liver damage at 75 mg/kg/day, po twice daily administered 4 hrs before viral challenge measured on day 3 of viral infection",Other,17606691.0,
152,370197,3,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as protection against viral infection at 10 mg/kg, po twice daily for 5 to 7 days twice daily administered 4 hrs before viral challenge",Other,17606691.0,
153,370198,6,1,,103512718,492405,Unspecified,,,,,Toxicity in po dosed C57BL/6 mouse administered twice daily for 5 days administered 4 hrs before viral challenge,Other,17606691.0,
154,370199,6,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against 5000 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as mean day of death at 30 mg/kg, po twice daily for 5 days administered 24 hrs post viral challenge",Other,17606691.0,
155,370200,6,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against 5000 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as mean day of death at 10 mg/kg, po twice daily for 5 days administered 24 hrs post viral challenge",Other,17606691.0,
156,370201,3,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against 5000 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as mean viral titer per 0.1 g of liver at 30 mg/kg, po twice daily administered 24 hrs post viral challenge measured on day 3 of viral infection",Other,17606691.0,
157,370202,3,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against 5000 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as mean viral titer per 0.1 g of liver at 10 mg/kg, po twice daily administered 24 hrs post viral challenge measured on day 3 of viral infection",Other,17606691.0,
158,370203,3,4,,103512718,492405,Unspecified,,,,,"Antiviral activity against 5000 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as animals with detectable virus level in liver at 30 mg/kg, po twice daily administered 24 hrs post viral challenge measured on day 3 of viral infection",Other,17606691.0,
159,370204,3,4,,103512718,492405,Unspecified,,,,,"Antiviral activity against 5000 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as animals with detectable virus level in liver at 10 mg/kg, po twice daily administered 24 hrs post viral challenge measured on day 3 of viral infection",Other,17606691.0,
160,370205,3,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against 5000 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as mean viral titer per 0.1 mL of serum at 30 mg/kg, po twice daily administered 24 hrs post viral challenge measured on day 3 of viral infection",Other,17606691.0,
161,370206,3,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against 5000 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as mean viral titer per 0.1 mL of serum at 10 mg/kg, po twice daily administered 24 hrs post viral challenge measured on day 3 of viral infection",Other,17606691.0,
162,370207,3,4,,103512718,492405,Unspecified,,,,,"Antiviral activity against 5000 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as animals with detectable virus level in serum at 10 mg/kg, po twice daily administered 24 hrs post viral challenge measured on day 3 of viral infection",Other,17606691.0,
163,370208,8,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against 5000 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as mean serum ALT levels at 10 mg/kg, po twice daily administered 24 hrs post viral challenge measured on day 3 of viral infection",Other,17606691.0,
164,370209,3,3,,103512718,492405,Active,,,,,"Antiviral activity against 50 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as survival at 30 mg/kg, po twice daily for 5 days administered 24 hrs post viral challenge",Other,17606691.0,
165,370210,3,3,,103512718,492405,Inactive,,,,,"Antiviral activity against 50 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as survival at 10 mg/kg, po twice daily for 5 days administered 24 hrs post viral challenge",Other,17606691.0,
166,370211,6,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against 50 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as mean day of death at 30 mg/kg, po twice daily for 5 days administered 24 hrs post viral challenge",Other,17606691.0,
167,370212,6,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against 50 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as mean day of death at 10 mg/kg, po twice daily for 5 days administered 24 hrs post viral challenge",Other,17606691.0,
168,370213,3,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against 50 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as mean viral titer per 0.1 g of liver at 30 mg/kg, po twice daily administered 24 hrs post viral challenge measured on day 3 of viral infection",Other,17606691.0,
169,370214,3,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against 50 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as mean viral titer per 0.1 g of liver at 10 mg/kg, po twice daily administered 24 hrs post viral challenge measured on day 3 of viral infection",Other,17606691.0,
170,370215,3,4,,103512718,492405,Unspecified,,,,,"Antiviral activity against 50 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as animals with detectable virus level in liver at 30 mg/kg, po twice daily administered 24 hrs post viral challenge measured on day 3 of viral infection",Other,17606691.0,
171,370216,3,4,,103512718,492405,Unspecified,,,,,"Antiviral activity against 50 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as animals with detectable virus level in liver at 10 mg/kg, po twice daily administered 24 hrs post viral challenge measured on day 3 of viral infection",Other,17606691.0,
172,370217,3,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against 50 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as mean viral titer per 0.1 mL of serum at 30 mg/kg, po twice daily administered 24 hrs post viral challenge measured on day 3 of viral infection",Other,17606691.0,
173,370218,3,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against 50 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as mean viral titer per 0.1 mL of serum at 10 mg/kg, po twice daily administered 24 hrs post viral challenge measured on day 3 of viral infection",Other,17606691.0,
174,370219,3,4,,103512718,492405,Unspecified,,,,,"Antiviral activity against 50 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as animals with detectable virus level in serum at 30 mg/kg, po twice daily administered 24 hrs post viral challenge measured on day 3 of viral infection",Other,17606691.0,
175,370220,3,4,,103512718,492405,Unspecified,,,,,"Antiviral activity against 50 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as animals with detectable virus level in serum at 10 mg/kg, po twice daily administered 24 hrs post viral challenge measured on day 3 of viral infection",Other,17606691.0,
176,370221,8,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against 50 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as mean serum ALT levels at 30 mg/kg, po twice daily administered 24 hrs post viral challenge measured on day 3 of viral infection",Other,17606691.0,
177,370222,8,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against 50 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as mean serum ALT levels at 10 mg/kg, po twice daily administered 24 hrs post viral challenge measured on day 3 of viral infection",Other,17606691.0,
178,370223,3,4,,103512718,492405,Unspecified,,,,,"Antiviral activity against 5000 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as survival at 10 mg/kg, po twice daily for 5 days administered 24 hrs post viral challenge",Other,17606691.0,
179,370224,3,4,,103512718,492405,Unspecified,,,,,"Antiviral activity against Punta Toro virus Adames infected Syrian golden hamster assessed as survival at 60 mg/kg, po twice daily for 6 days administered 4 hrs before viral challenge",Other,17606691.0,
180,370225,3,4,,103512718,492405,Unspecified,,,,,"Antiviral activity against Punta Toro virus Adames infected Syrian golden hamster assessed as survival at 30 mg/kg, po twice daily for 6 days administered 4 hrs before viral challenge",Other,17606691.0,
181,370226,6,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against Punta Toro virus Adames infected Syrian golden hamster assessed as mean day of death at 60 mg/kg, po twice daily for 6 days administered 4 hrs before viral challenge",Other,17606691.0,
182,370227,6,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against Punta Toro virus Adames infected Syrian golden hamster assessed as mean day of death at 30 mg/kg, po twice daily for 6 days administered 4 hrs before viral challenge",Other,17606691.0,
183,370228,6,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against Punta Toro virus Adames infected Syrian golden hamster assessed as mean day of death at 15 mg/kg, po twice daily for 6 days administered 4 hrs before viral challenge",Other,17606691.0,
184,370229,3,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against Punta Toro virus Adames infected Syrian golden hamster assessed as mean viral titer per 0.1 g of liver at 60 mg/kg, po twice daily administered 4 hrs before viral challenge measured on day 4 of viral infection",Other,17606691.0,
185,370230,3,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against Punta Toro virus Adames infected Syrian golden hamster assessed as mean viral titer per 0.1 g of liver at 30 mg/kg, po twice daily administered 4 hrs before viral challenge measured on day 4 of viral infection",Other,17606691.0,
186,370231,3,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against Punta Toro virus Adames infected Syrian golden hamster assessed as mean viral titer per 0.1 g of liver at 15 mg/kg, po twice daily administered 4 hrs before viral challenge measured on day 4 of viral infection",Other,17606691.0,
187,370232,3,4,,103512718,492405,Unspecified,,,,,"Antiviral activity against Punta Toro virus Adames infected Syrian golden hamster assessed as animals with detectable virus level in liver at 60 mg/kg, po twice daily administered 4 hrs before viral challenge measured on day 4 of viral infection",Other,17606691.0,
188,370233,3,4,,103512718,492405,Unspecified,,,,,"Antiviral activity against Punta Toro virus Adames infected Syrian golden hamster assessed as animals with detectable virus level in liver at 30 mg/kg, po twice daily administered 4 hrs before viral challenge measured on day 4 of viral infection",Other,17606691.0,
189,370234,3,4,,103512718,492405,Unspecified,,,,,"Antiviral activity against Punta Toro virus Adames infected Syrian golden hamster assessed as animals with detectable virus level in liver at 15 mg/kg, po twice daily administered 4 hrs before viral challenge measured on day 4 of viral infection",Other,17606691.0,
190,370235,3,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against Punta Toro virus Adames infected Syrian golden hamster assessed as mean viral titer per 0.1 mL of serum at 60 mg/kg, po twice daily administered 4 hrs before viral challenge measured on day 4 of viral infection",Other,17606691.0,
191,392525,6,2,,103512718,492405,Active,,,0.08900000000000001,IC50,Antiviral activity against influenza B virus,Confirmatory,19112024.0,
192,392526,6,2,,103512718,492405,Active,,,0.044000000000000004,IC50,Antiviral activity against Influenza C virus,Confirmatory,19112024.0,
193,392527,6,2,,103512718,492405,Active,,,0.16,IC50,Antiviral activity against influenza H1N1 virus,Confirmatory,19112024.0,
194,392528,6,2,,103512718,492405,Active,,,0.048,IC50,Antiviral activity against influenza H2N2 virus,Confirmatory,19112024.0,
195,395665,3,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against Punta Toro virus Adames infected Syrian golden hamster assessed as mean viral titer per 0.1 mL of serum at 30 mg/kg, po twice daily administered 4 hrs before viral challenge measured on day 4 of viral infection",Other,17606691.0,
196,395666,3,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against Punta Toro virus Adames infected Syrian golden hamster assessed as mean viral titer per 0.1 mL of serum at 15 mg/kg, po twice daily administered 4 hrs before viral challenge measured on day 4 of viral infection",Other,17606691.0,
197,395667,3,4,,103512718,492405,Unspecified,,,,,"Antiviral activity against Punta Toro virus Adames infected Syrian golden hamster assessed as animals with detectable virus level in serum at 60 mg/kg, po twice daily administered 4 hrs before viral challenge measured on day 4 of viral infection",Other,17606691.0,
198,395668,3,4,,103512718,492405,Unspecified,,,,,"Antiviral activity against Punta Toro virus Adames infected Syrian golden hamster assessed as animals with detectable virus level in serum at 30 mg/kg, po twice daily administered 4 hrs before viral challenge measured on day 4 of viral infection",Other,17606691.0,
199,395669,3,4,,103512718,492405,Unspecified,,,,,"Antiviral activity against Punta Toro virus Adames infected Syrian golden hamster assessed as animals with detectable virus level in serum at 15 mg/kg, po twice daily administered 4 hrs before viral challenge measured on day 4 of viral infection",Other,17606691.0,
200,395670,8,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against Punta Toro virus Adames infected Syrian golden hamster assessed as mean serum ALT levels at 60 mg/kg, po twice daily administered 4 hrs before viral challenge measured on day 4 of viral infection",Other,17606691.0,
201,395671,8,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against Punta Toro virus Adames infected Syrian golden hamster assessed as mean serum ALT levels at 30 mg/kg, po twice daily administered 4 hrs before viral challenge measured on day 4 of viral infection",Other,17606691.0,
202,395672,8,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against Punta Toro virus Adames infected Syrian golden hamster assessed as mean serum ALT levels at 15 mg/kg, po twice daily administered 4 hrs before viral challenge measured on day 4 of viral infection",Other,17606691.0,
203,395673,3,3,,103512718,492405,Active,,,,,"Antiviral activity against Punta Toro virus Adames infected Syrian golden hamster assessed as inhibition of liver damage at 60 mg/kg, po twice daily administered 4 hrs before viral challenge measured on day 4 of viral infection",Other,17606691.0,
204,395674,3,3,,103512718,492405,Active,,,,,"Antiviral activity against Punta Toro virus Adames infected Syrian golden hamster assessed as inhibition of liver damage at 30 mg/kg, po twice daily administered 4 hrs before viral challenge measured on day 4 of viral infection",Other,17606691.0,
205,395675,3,4,,103512718,492405,Unspecified,,,,,"Antiviral activity against Punta Toro virus Adames infected Syrian golden hamster assessed as survival at 15 mg/kg, po twice daily for 6 days administered 4 hrs before viral challenge",Other,17606691.0,
206,395676,6,2,,103512718,492405,Active,,,5.0,EC50,Antiviral activity against Junin virus Candid-1 in Vero cells assessed as inhibition of virus-induced visual cytopathic effect after 7 to 8 days,Confirmatory,17606691.0,
207,395677,6,2,,103512718,492405,Active,,,6.0,EC50,Antiviral activity against Pichinde virus An 4763 in Vero cells assessed as inhibition of virus-induced visual cytopathic effect after 7 to 8 days,Confirmatory,17606691.0,
208,395678,6,2,,103512718,492405,Active,,,6.0,EC50,Antiviral activity against Tacaribe virus TRVL11573 in Vero cells assessed as inhibition of virus-induced visual cytopathic effect after 7 to 8 days,Confirmatory,17606691.0,
209,395679,6,2,,103512718,492405,Unspecified,,,1114.0,CC50,Cytotoxicity against african green monkey Vero cells after 7 to 8 days by neutral-red dye uptake assay,Confirmatory,17606691.0,
210,395680,3,4,,103512718,492405,Unspecified,,,,,"Selectivity index, ratio of CC50 for african green monkey Vero cells to EC50 for Junin virus Candid-1",Other,17606691.0,
211,395681,3,4,,103512718,492405,Unspecified,,,,,"Selectivity index, ratio of CC50 for african green monkey Vero cells to EC50 for Pichinde virus An 4763",Other,17606691.0,
212,395682,3,4,,103512718,492405,Unspecified,,,,,"Selectivity index, ratio of CC50 for african green monkey Vero cells to EC50 for Tacaribe virus TRVL11573",Other,17606691.0,
213,395683,7,1,,103512718,492405,Active,,,,,Antiviral activity against Junin virus Candid-1 assessed as reduction of 1 log10 unit viral titer yields after 7 to 8 days,Other,17606691.0,
214,395684,7,1,,103512718,492405,Active,,,,,Antiviral activity against Pichinde virus An 4763 assessed as reduction of 1 log10 unit viral titer yields after 7 to 8 days,Other,17606691.0,
215,395685,7,1,,103512718,492405,Active,,,,,Antiviral activity against Tacaribe virus TRVL11573 assessed as reduction of 1 log10 unit viral titer yields after 7 to 8 days,Other,17606691.0,
216,395686,3,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against Pichinde virus An 4763 infected Syrian golden hamster assessed as survival at 60 mg/kg, po twice daily for 7 days administered 4 hrs before viral-challenge",Other,17606691.0,
217,395687,3,3,,103512718,492405,Unspecified,,,,,Antiviral activity against Pichinde virus An 4763 infected Syrian golden hamster assessed as decrease in survival administered po twice daily for 7 days administered 4 hrs before viral-challenge,Other,17606691.0,
218,395688,6,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against Pichinde virus An 4763 infected Syrian golden hamster assessed as mean day of death at 60 mg/kg, po twice daily for 7 days administered 4 hrs before viral-challenge",Other,17606691.0,
219,395689,6,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against Pichinde virus An 4763 infected Syrian golden hamster assessed as mean day of death at 30 mg/kg, po twice daily for 7 days administered 4 hrs before viral-challenge",Other,17606691.0,
220,395690,6,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against Pichinde virus An 4763 infected Syrian golden hamster assessed as mean day of death at 15 mg/kg, po twice daily for 7 days administered 4 hrs before viral-challenge",Other,17606691.0,
221,395691,6,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against Pichinde virus An 4763 infected Syrian golden hamster assessed as mean day of death at 40 mg/kg, po twice daily for 7 days administered 4 hrs before viral-challenge",Other,17606691.0,
222,395692,3,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against Pichinde virus An 4763 infected Syrian golden hamster assessed as mean viral titer per 0.1 g of liver at 60 mg/kg, po twice daily for 7 days administered 4 hrs before viral-challenge measured on day 7 of viral infection",Other,17606691.0,
223,395693,3,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against Pichinde virus An 4763 infected Syrian golden hamster assessed as mean viral titer per 0.1 g of liver at 30 mg/kg, po twice daily for 7 days administered 4 hrs before viral-challenge measured on day 7 of viral infection",Other,17606691.0,
224,395694,3,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against Pichinde virus An 4763 infected Syrian golden hamster assessed as mean viral titer per 0.1 g of liver at 15 mg/kg, po twice daily for 7 days administered 4 hrs before viral-challenge measured on day 7 of viral infection",Other,17606691.0,
225,395695,3,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against Pichinde virus An 4763 infected Syrian golden hamster assessed as mean viral titer per 0.1 g of liver at 40 mg/kg, po twice daily for 7 days administered 4 hrs before viral-challenge measured on day 7 of viral infection",Other,17606691.0,
226,395696,3,4,,103512718,492405,Unspecified,,,,,"Antiviral activity against Pichinde virus An 4763 infected Syrian golden hamster assessed as animals with detectable virus level in liver at 60 mg/kg, po twice daily for 7 days administered 4 hrs before viral-challenge measured on day 7 of viral infection",Other,17606691.0,
227,395697,3,4,,103512718,492405,Unspecified,,,,,"Antiviral activity against Pichinde virus An 4763 infected Syrian golden hamster assessed as animals with detectable virus level in liver at 30 mg/kg, po twice daily for 7 days administered 4 hrs before viral-challenge measured on day 7 of viral infection",Other,17606691.0,
228,395698,3,4,,103512718,492405,Unspecified,,,,,"Antiviral activity against Pichinde virus An 4763 infected Syrian golden hamster assessed as animals with detectable virus level in liver at 15 mg/kg, po twice daily for 7 days administered 4 hrs before viral-challenge measured on day 7 of viral infection",Other,17606691.0,
229,395699,3,4,,103512718,492405,Unspecified,,,,,"Antiviral activity against Pichinde virus An 4763 infected Syrian golden hamster assessed as animals with detectable virus level in liver at 40 mg/kg, po twice daily for 7 days administered 4 hrs before viral-challenge measured on day 7 of viral infection",Other,17606691.0,
230,395700,3,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against Pichinde virus An 4763 infected Syrian golden hamster assessed as mean viral titer per 0.1 mL of serum at 60 mg/kg, po twice daily for 7 days administered 4 hrs before viral-challenge measured on day 7 of viral infection",Other,17606691.0,
231,395701,3,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against Pichinde virus An 4763 infected Syrian golden hamster assessed as mean viral titer per 0.1 mL of serum at 30 mg/kg, po twice daily for 7 days administered 4 hrs before viral-challenge measured on day 7 of viral infection",Other,17606691.0,
232,395702,3,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against Pichinde virus An 4763 infected Syrian golden hamster assessed as mean viral titer per 0.1 mL of serum at 15 mg/kg, po twice daily for 7 days administered 4 hrs before viral-challenge measured on day 7 of viral infection",Other,17606691.0,
233,395703,3,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against Pichinde virus An 4763 infected Syrian golden hamster assessed as mean viral titer per 0.1 mL of serum at 40 mg/kg, po twice daily for 7 days administered 4 hrs before viral-challenge measured on day 7 of viral infection",Other,17606691.0,
234,395704,3,4,,103512718,492405,Unspecified,,,,,"Antiviral activity against Pichinde virus An 4763 infected Syrian golden hamster assessed as animals with detectable virus level in serum at 60 mg/kg, po twice daily for 7 days administered 4 hrs before viral-challenge measured on day 7 of viral infection",Other,17606691.0,
235,395705,3,4,,103512718,492405,Unspecified,,,,,"Antiviral activity against Pichinde virus An 4763 infected Syrian golden hamster assessed as animals with detectable virus level in serum at 30 mg/kg, po twice daily for 7 days administered 4 hrs before viral-challenge measured on day 7 of viral infection",Other,17606691.0,
236,395706,3,4,,103512718,492405,Unspecified,,,,,"Antiviral activity against Pichinde virus An 4763 infected Syrian golden hamster assessed as animals with detectable virus level in serum at 15 mg/kg, po twice daily for 7 days administered 4 hrs before viral-challenge measured on day 7 of viral infection",Other,17606691.0,
237,395708,8,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against Pichinde virus An 4763 infected Syrian golden hamster assessed as mean serum ALT levels at 60 mg/kg, po twice daily for 7 days administered 4 hrs before viral-challenge measured on day 7 of viral infection",Other,17606691.0,
238,395709,8,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against Pichinde virus An 4763 infected Syrian golden hamster assessed as mean serum ALT levels at 30 mg/kg, po twice daily for 7 days administered 4 hrs before viral-challenge measured on day 7 of viral infection",Other,17606691.0,
239,395710,8,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against Pichinde virus An 4763 infected Syrian golden hamster assessed as mean serum ALT levels at 15 mg/kg, po twice daily for 7 days administered 4 hrs before viral-challenge measured on day 7 of viral infection",Other,17606691.0,
240,395711,8,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against Pichinde virus An 4763 infected Syrian golden hamster assessed as mean serum ALT levels at 40 mg/kg, po twice daily for 7 days administered 4 hrs before viral-challenge measured on day 7 of viral infection",Other,17606691.0,
241,395712,3,3,,103512718,492405,Active,,,,,"Antiviral activity against Pichinde virus An 4763 infected Syrian golden hamster assessed as inhibition of liver damage at 40 mg/kg, po twice daily for 7 days administered 4 hrs before viral-challenge measured on day 7 of viral infection",Other,17606691.0,
242,395714,6,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against Pichinde virus An 4763 infected Syrian golden hamster assessed as mean day of death at 50 mg/kg, po twice daily for 7 days administered 24 hrs post viral-challenge",Other,17606691.0,
243,395930,6,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against Pichinde virus An 4763 infected Syrian golden hamster assessed as mean day of death at 20 mg/kg, po twice daily for 7 days administered 24 hrs post viral-challenge",Other,17606691.0,
244,395931,3,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against Pichinde virus An 4763 infected Syrian golden hamster assessed as mean viral titer per 0.1 g of liver at 50 mg/kg, po twice daily for 7 days administered 24 hrs post viral-challenge measured on day 7 of viral infection",Other,17606691.0,
245,395932,3,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against Pichinde virus An 4763 infected Syrian golden hamster assessed as mean viral titer per 0.1 g of liver at 20 mg/kg, po twice daily for 7 days administered 24 hrs post viral-challenge measured on day 7 of viral infection",Other,17606691.0,
246,395933,3,4,,103512718,492405,Unspecified,,,,,"Antiviral activity against Pichinde virus An 4763 infected Syrian golden hamster assessed as animals with detectable virus level in liver at 50 mg/kg, po twice daily for 7 days administered 24 hrs post viral-challenge measured on day 7 of viral infection",Other,17606691.0,
247,395934,3,4,,103512718,492405,Unspecified,,,,,"Antiviral activity against Pichinde virus An 4763 infected Syrian golden hamster assessed as animals with detectable virus level in liver at 20 mg/kg, po twice daily for 7 days administered 24 hrs post viral-challenge measured on day 7 of viral infection",Other,17606691.0,
248,395935,3,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against Pichinde virus An 4763 infected Syrian golden hamster assessed as mean viral titer per 0.1 mL of serum at 50 mg/kg, po twice daily for 7 days administered 24 hrs post viral-challenge measured on day 7 of viral infection",Other,17606691.0,
249,395936,3,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against Pichinde virus An 4763 infected Syrian golden hamster assessed as mean viral titer per 0.1 mL of serum at 20 mg/kg, po twice daily for 7 days administered 24 hrs post viral-challenge",Other,17606691.0,
250,395937,3,4,,103512718,492405,Unspecified,,,,,"Antiviral activity against Pichinde virus An 4763 infected Syrian golden hamster assessed as animals with detectable virus level in serum at 50 mg/kg, po twice daily for 7 days administered 24 hrs post viral-challenge measured on day 7 of viral infection",Other,17606691.0,
251,395938,3,4,,103512718,492405,Unspecified,,,,,"Antiviral activity against Pichinde virus An 4763 infected Syrian golden hamster assessed as animals with detectable virus level in serum at 20 mg/kg, po twice daily for 7 days administered 24 hrs post viral-challenge measured on day 7 of viral infection",Other,17606691.0,
252,395939,8,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against Pichinde virus An 4763 infected Syrian golden hamster assessed as mean serum ALT levels at 50 mg/kg, po twice daily for 7 days administered 24 hrs post viral-challenge measured on day 7 of viral infection",Other,17606691.0,
253,395940,8,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against Pichinde virus An 4763 infected Syrian golden hamster assessed as mean serum ALT levels at 20 mg/kg, po twice daily for 7 days administered 24 hrs post viral-challenge measured on day 7 of viral infection",Other,17606691.0,
254,395941,3,3,,103512718,492405,Active,,,,,"Antiviral activity against Pichinde virus An 4763 infected Syrian golden hamster assessed as inhibition of liver damage at 20 mg/kg, po twice daily for 7 days administered 24 hrs post viral-challenge measured on day 7 of viral infection",Other,17606691.0,
255,395942,8,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against Pichinde virus An 4763 infected Syrian golden hamster assessed as mean serum ALT levels at 50 mg/kg, po twice daily for 7 days administered 72 hrs post viral-challenge measured on day 7 of viral infection measured on day 7 of viral infection",Other,17606691.0,
256,395943,3,3,,103512718,492405,Unspecified,,,,,Metabolic stability in po dosed mouse assessed as drug remaining after 6 hrs,Other,17606691.0,
257,395944,3,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against Pichinde virus An 4763 infected Syrian golden hamster assessed as survival at 50 mg/kg, po twice daily for 7 days administered 72 hrs post viral-challenge",Other,17606691.0,
258,395946,6,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against Pichinde virus An 4763 infected Syrian golden hamster assessed as mean day of death at 50 mg/kg, po twice daily for 7 days administered 72 hrs post viral-challenge measured on day 7 of viral infection",Other,17606691.0,
259,395947,6,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against Pichinde virus An 4763 infected Syrian golden hamster assessed as mean day of death at 20 mg/kg, po twice daily for 7 days administered 72 hrs post viral-challenge measured on day 7 of viral infection",Other,17606691.0,
260,395948,3,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against Pichinde virus An 4763 infected Syrian golden hamster assessed as mean viral titer per 0.1 g of liver at 50 mg/kg, po twice daily for 7 days administered 72 hrs post viral-challenge measured on day 7 of viral infection",Other,17606691.0,
261,395949,3,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against Pichinde virus An 4763 infected Syrian golden hamster assessed as mean viral titer per 0.1 g of liver at 20 mg/kg, po twice daily for 7 days administered 72 hrs post viral-challenge measured on day 7 of viral infection",Other,17606691.0,
262,395950,3,4,,103512718,492405,Unspecified,,,,,"Antiviral activity against Pichinde virus An 4763 infected Syrian golden hamster assessed as animals with detectable virus level in liver at 50 mg/kg, po twice daily for 7 days administered 72 hrs post viral-challenge measured on day 7 of viral infection",Other,17606691.0,
263,395951,3,4,,103512718,492405,Unspecified,,,,,"Antiviral activity against Pichinde virus An 4763 infected Syrian golden hamster assessed as animals with detectable virus level in liver at 20 mg/kg, po twice daily for 7 days administered 72 hrs post viral-challenge measured on day 7 of viral infection",Other,17606691.0,
264,395952,3,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against Pichinde virus An 4763 infected Syrian golden hamster assessed as mean viral titer per 0.1 mL of serum at 50 mg/kg, po twice daily for 7 days administered 72 hrs post viral-challenge measured on day 7 of viral infection",Other,17606691.0,
265,395953,3,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against Pichinde virus An 4763 infected Syrian golden hamster assessed as mean viral titer per 0.1 mL of serum at 20 mg/kg, po twice daily for 7 days administered 72 hrs post viral-challenge measured on day 7 of viral infection",Other,17606691.0,
266,395954,3,4,,103512718,492405,Unspecified,,,,,"Antiviral activity against Pichinde virus An 4763 infected Syrian golden hamster assessed as animals with detectable virus level in serum at 50 mg/kg, po twice daily for 7 days administered 72 hrs post viral-challenge measured on day 7 of viral infection",Other,17606691.0,
267,395955,3,4,,103512718,492405,Unspecified,,,,,"Antiviral activity against Pichinde virus An 4763 infected Syrian golden hamster assessed as animals with detectable virus level in serum at 20 mg/kg, po twice daily for 7 days administered 72 hrs post viral-challenge measured on day 7 of viral infection",Other,17606691.0,
268,395956,8,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against Pichinde virus An 4763 infected Syrian golden hamster assessed as mean serum ALT levels at 20 mg/kg, po twice daily for 7 days administered 72 hrs post viral-challenge measured on day 7 of viral infection",Other,17606691.0,
269,395958,6,1,,103512718,492405,Unspecified,,,,,Toxicity in Pichinde virus An 4763 infected po dosed Syrian golden hamster administered twice daily 72 hrs post viral-challenge,Other,17606691.0,
270,395959,6,2,,103512718,492405,Active,,,0.083,EC50,Antiviral activity against influenza A virus,Confirmatory,17606691.0,
271,395960,6,2,,103512718,492405,Active,,,31.0,EC50,Antiviral activity against Poliovirus,Confirmatory,17606691.0,
272,395961,6,2,,103512718,492405,Unspecified,,,146.0,EC50,Antiviral activity against Rhinovirus,Confirmatory,17606691.0,
273,395962,6,2,,103512718,492405,Unspecified,,,261.0,EC50,Antiviral activity against Respiratory syncytial virus,Confirmatory,17606691.0,
274,395964,3,3,,103512718,492405,Unspecified,,,,,% Compound cleared in virus-infected po dosed mouse after 6 hrs,Other,17606691.0,
275,395965,6,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as mean day of death at 30 mg/kg, po twice daily for 5 days administered 24 hrs post viral challenge",Other,17606691.0,
276,395966,6,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as mean day of death at 10 mg/kg, po twice daily for 5 days administered 24 hrs post viral challenge",Other,17606691.0,
277,395967,3,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as mean viral titer per 0.1 g of liver at 30 mg/kg, po twice daily administered 24 hrs post viral challenge measured on day 3 of viral infection",Other,17606691.0,
278,395968,3,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as mean viral titer per 0.1 g of liver at 10 mg/kg, po twice daily administered 24 hrs post viral challenge measured on day 3 of viral infection",Other,17606691.0,
279,395969,3,4,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as animals with detectable virus level in liver at 30 mg/kg, po twice daily administered 24 hrs post viral challenge measured on day 3 of viral infection",Other,17606691.0,
280,395970,3,4,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as animals with detectable virus level in liver at 10 mg/kg, po twice daily administered 24 hrs post viral challenge measured on day 3 of viral infection",Other,17606691.0,
281,395971,3,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as mean viral titer per 0.1 mL of serum at 30 mg/kg, po twice daily administered 24 hrs post viral challenge measured on day 3 of viral infection",Other,17606691.0,
282,395972,3,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as mean viral titer per 0.1 mL of serum at 10 mg/kg, po twice daily administered 24 hrs post viral challenge measured on day 3 of viral infection",Other,17606691.0,
283,395973,3,4,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as animals with detectable virus level in serum at 30 mg/kg, po twice daily administered 24 hrs post viral challenge measured on day 3 of viral infection",Other,17606691.0,
284,395974,3,4,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as animals with detectable virus level in serum at 10 mg/kg, po twice daily administered 24 hrs post viral challenge measured on day 3 of viral infection",Other,17606691.0,
285,395975,8,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as mean serum ALT levels at 30 mg/kg, po twice daily administered 24 hrs post viral challenge measured on day 3 of viral infection",Other,17606691.0,
286,395976,8,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against 500 PFU Punta Toro virus Adames infected C57BL/6 mouse assessed as mean serum ALT levels at 10 mg/kg, po twice daily administered 24 hrs post viral challenge measured on day 3 of viral infection",Other,17606691.0,
287,543657,1,3,,103512718,492405,Unspecified,,,,,"Toxicity in syrian golden hamster infected with 10'2 CCID50 Yellow fever virus Jimenez assessed as weight change at 400 mg/kg/day, po administered twice daily for 8 days started 1 day post viral infection",Other,18955536.0,
288,543658,4,2,,103512718,492405,Unspecified,,,180.0,EC50,Antiviral activity against Yellow fever virus 17D infected in African green monkey Vero cells assessed as inhibition of virus induced cytopathic effect by microscopic analysis,Confirmatory,18955536.0,
289,543659,4,2,,103512718,492405,Unspecified,,,270.0,EC50,Antiviral activity against Yellow fever virus 17D infected in African green monkey Vero cells assessed as inhibition of virus induced cytopathic effect after 2 hrs by NR dye uptake assay,Confirmatory,18955536.0,
290,543660,4,2,,103512718,492405,Unspecified,,,270.0,EC50,Antiviral activity against Yellow fever virus 17D infected in African green monkey Vero cells assessed as inhibition of virus induced cytopathic effect by luciferase reporter gene assay,Confirmatory,18955536.0,
291,543661,4,2,,103512718,492405,Unspecified,,,6370.0,CC50,Cytotoxicity against African green monkey Vero cells by luciferase-based cell viability assay,Confirmatory,18955536.0,
292,543662,2,4,,103512718,492405,Unspecified,,,,,Antiviral activity against Yellow fever virus 17D infected in African green monkey Vero cells assessed as reduction in virus yield,Other,18955536.0,
293,543663,1,4,,103512718,492405,Unspecified,,,,,"Selectivity index, ratio of CC50 for African green monkey vero cells to EC90 for Yellow fever virus 17D",Other,18955536.0,
294,543664,2,4,,103512718,492405,Active,,,,,Antiviral activity against Yellow fever virus 17D infected in African green monkey Vero cells assessed as time required for inhibition of viral replication at 6400 uM up to 12 hrs post-viral infection,Other,18955536.0,
295,543665,6,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against 10'2 CCID50 Yellow fever virus Jimenez infected in syrian golden hamster assessed as serum ALT level at 400 mg/kg/day, po administered twice daily for 8 days started 4 hrs prior to viral infection",Other,18955536.0,
296,543666,6,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against 10'2 CCID50 Yellow fever virus Jimenez infected in syrian golden hamster assessed as serum ALT level at 100 mg/kg/day, po administered twice daily for 8 days started 4 hrs prior to viral infection",Other,18955536.0,
297,543667,1,3,,103512718,492405,Unspecified,,,,,"Toxicity in syrian golden hamster infected with 10'2 CCID50 Yellow fever virus Jimenez assessed as weight change at 400 mg/kg/day, po administered twice daily for 8 days started 4 hrs prior to viral infection relative to control",Other,18955536.0,
298,543668,1,3,,103512718,492405,Unspecified,,,,,"Toxicity in syrian golden hamster infected with 10'2 CCID50 Yellow fever virus Jimenez assessed as weight change at 100 mg/kg/day, po administered twice daily for 8 days started 4 hrs prior to viral infection",Other,18955536.0,
299,543669,2,4,,103512718,492405,Active,,,,,Antiviral activity against 10'2 CCID50 Yellow fever virus Jimenez infected in syrian golden hamster assessed as reduction in viral titer in liver at 200 mg/kg/day administered twice daily for 8 days started 6 days post infection by quantitative RT-PCR analysis,Other,18955536.0,
300,543671,6,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against 10'2 CCID50 Yellow fever virus Jimenez infected in syrian golden hamster assessed as serum ALT level at 200 mg/kg/day, po administered twice daily for 8 days started 4 hrs prior to viral infection",Other,18955536.0,
301,543672,1,3,,103512718,492405,Unspecified,,,,,"Toxicity in syrian golden hamster infected with 10'2 CCID50 Yellow fever virus Jimenez assessed as weight change at 200 mg/kg/day, po administered twice daily for 8 days started 4 hrs prior to viral infection relative to control",Other,18955536.0,
302,543677,2,4,,103512718,492405,Inactive,,,,,"Antiviral activity against 10'2 CCID50 Yellow fever virus Jimenez infected in syrian golden hamster assessed as serum AST level at 400 mg/kg/day, po administered twice daily for 8 days started 4 hrs prior to viral infection",Other,18955536.0,
303,543678,2,4,,103512718,492405,Inactive,,,,,"Antiviral activity against 10'2 CCID50 Yellow fever virus Jimenez infected in syrian golden hamster assessed as serum AST level at 200 mg/kg/day, po administered twice daily for 8 days started 4 hrs prior to viral infection",Other,18955536.0,
304,543679,2,4,,103512718,492405,Inactive,,,,,"Antiviral activity 10'2 CCID50 Yellow fever virus Jimenez infected in syrian golden hamster assessed as serum AST level at 100 mg/kg/day, po administered twice daily for 8 days started 4 hrs prior to viral infection",Other,18955536.0,
305,543680,2,4,,103512718,492405,Inactive,,,,,"Antiviral activity against 10'2 CCID50 Yellow fever virus Jimenez infected in syrian golden hamster assessed as serum AST level at 50 mg/kg/day, po administered twice daily for 8 days started 4 hrs prior to viral infection",Other,18955536.0,
306,543681,2,4,,103512718,492405,Inactive,,,,,"Antiviral activity against 10'2 CCID50 Yellow fever virus Jimenez infected in syrian golden hamster assessed as serum AST level at 32 mg/kg/day, po administered twice daily for 8 days started 4 hrs prior to viral infection",Other,18955536.0,
307,543682,2,4,,103512718,492405,Inactive,,,,,"Antiviral activity against 10'2 CCID50 Yellow fever virus Jimenez infected in syrian golden hamster assessed as serum AST level at 10 mg/kg/day, po administered twice daily for 8 days started 4 hrs prior to viral infection",Other,18955536.0,
308,543683,2,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against 10'2 CCID50 Yellow fever virus Jimenez infected in syrian golden hamster assessed as mean day of death of mice at 400 mg/kg/day, po administered twice daily for 8 days started 4 hrs prior to viral infection relative to control",Other,18955536.0,
309,543684,2,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against 10'2 CCID50 Yellow fever virus Jimenez infected in syrian golden hamster assessed as mean day of death of mice at 200 mg/kg/day, po administered twice daily for 8 days started 4 hrs prior to viral infection relative to control",Other,18955536.0,
310,543685,2,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against 10'2 CCID50 Yellow fever virus Jimenez infected in syrian golden hamster assessed as mean day of death of mice at 100 mg/kg/day, po administered twice daily for 8 days started 4 hrs prior to viral infection relative to control",Other,18955536.0,
311,543689,2,3,,103512718,492405,Active,,,,,"Antiviral activity against 10'2 CCID50 Yellow fever virus Jimenez infected in syrian golden hamster assessed as survival of animal at 400 mg/kg/day, po administered twice daily for 8 days started 4 hrs prior to viral infection",Other,18955536.0,
312,543690,2,3,,103512718,492405,Active,,,,,"Antiviral activity against 10'2 CCID50 Yellow fever virus Jimenez infected in syrian golden hamster assessed as serum survival of animal at 200 mg/kg/day, po administered twice daily for 8 days started 4 hrs prior to viral infection",Other,18955536.0,
313,543691,2,3,,103512718,492405,Inactive,,,,,"Antiviral activity against 10'2 CCID50 Yellow fever virus Jimenez infected in syrian golden hamster assessed as serum survival of animal at 100 mg/kg/day, po administered twice daily for 8 days started 4 hrs prior to viral infection",Other,18955536.0,
314,543694,1,3,,103512718,492405,Unspecified,,,,,"Toxicity in syrian golden hamster assessed as number of animals alive at 400 mg/kg/day, po BID administered for 8 days",Other,18955536.0,
315,543695,1,3,,103512718,492405,Unspecified,,,,,"Toxicity in syrian golden hamster assessed as weight change at 400 mg/kg/day, po BID administered for 8 days",Other,18955536.0,
316,543876,6,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against 10'2 CCID50 Yellow fever virus Jimenez infected in syrian golden hamster assessed as serum ALT level at 400 mg/kg/day, po administered daily for days started 1 day post viral challenge",Other,18955536.0,
317,543877,6,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against 10'2 CCID50 Yellow fever virus Jimenez infected in syrian golden hamster assessed as serum AST level at 400 mg/kg/day, po administered daily for days started 1 day post viral challenge",Other,18955536.0,
318,543878,6,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against 10'2 CCID50 Yellow fever virus Jimenez infected in syrian golden hamster assessed as serum ALT level at 400 mg/kg/day, po administered daily for days started 2 day post viral challenge",Other,18955536.0,
319,543879,6,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against 10'2 CCID50 Yellow fever virus Jimenez infected in syrian golden hamster assessed as serum AST level at 400 mg/kg/day, po administered daily for days started 2 day post viral challenge",Other,18955536.0,
320,543880,6,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against 10'2 CCID50 Yellow fever virus Jimenez infected in syrian golden hamster assessed as serum ALT level at 400 mg/kg/day, po administered daily for days started 3 day post viral challenge",Other,18955536.0,
321,543881,6,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against 10'2 CCID50 Yellow fever virus Jimenez infected in syrian golden hamster assessed as serum AST level at 400 mg/kg/day, po administered daily for days started 3 day post viral challenge",Other,18955536.0,
322,543882,6,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against 10'2 CCID50 Yellow fever virus Jimenez infected in syrian golden hamster assessed as serum ALT level at 400 mg/kg/day, po administered daily for days started 4 day post viral challenge",Other,18955536.0,
323,543883,6,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against 10'2 CCID50 Yellow fever virus Jimenez infected in syrian golden hamster assessed as serum AST level at 400 mg/kg/day, po administered daily for days started 4 day post viral challenge",Other,18955536.0,
324,543884,6,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against 10'2 CCID50 Yellow fever virus Jimenez infected in syrian golden hamster assessed as serum ALT level at 400 mg/kg/day, po administered daily for days started 5 day post viral challenge",Other,18955536.0,
325,543885,6,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against 10'2 CCID50 Yellow fever virus Jimenez infected in syrian golden hamster assessed as serum AST level at 400 mg/kg/day, po administered daily for days started 5 day post viral challenge",Other,18955536.0,
326,543886,6,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against 10'2 CCID50 Yellow fever virus Jimenez infected in syrian golden hamster assessed as serum ALT level in surviving animals at 400 mg/kg/day, po administered 4 days post viral infection",Other,18955536.0,
327,543887,6,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against 10'2 CCID50 Yellow fever virus Jimenez infected in syrian golden hamster assessed as serum ALT level in surviving animals at 400 mg/kg/day, po administered 5 days post viral infection",Other,18955536.0,
328,543888,6,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against 10'2 CCID50 Yellow fever virus Jimenez infected in syrian golden hamster assessed as serum AST level in surviving animals at 400 mg/kg/day, po administered 4 days post viral infection",Other,18955536.0,
329,543889,6,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against 10'2 CCID50 Yellow fever virus Jimenez infected in syrian golden hamster assessed as serum AST level in surviving animals at 400 mg/kg/day, po administered 5 days post viral infection",Other,18955536.0,
330,543890,6,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against 10'2 CCID50 Yellow fever virus Jimenez infected in syrian golden hamster assessed as serum ALT level in non surviving animals at 400 mg/kg/day, po administered 4 days post viral infection",Other,18955536.0,
331,543891,6,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against 10'2 CCID50 Yellow fever virus Jimenez infected in syrian golden hamster assessed as serum ALT level in non surviving animals at 400 mg/kg/day, po administered 5 days post viral infection",Other,18955536.0,
332,543892,6,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against 10'2 CCID50 Yellow fever virus Jimenez infected in syrian golden hamster assessed as serum AST level in non surviving animals at 400 mg/kg/day, po administered 4 days post viral infection",Other,18955536.0,
333,543893,6,1,,103512718,492405,Unspecified,,,,,"Antiviral activity against 10'2 CCID50 Yellow fever virus Jimenez infected in syrian golden hamster assessed as serum AST level in non surviving animals at 400 mg/kg/day, po administered 5 days post viral infection",Other,18955536.0,
334,543894,1,3,,103512718,492405,Unspecified,,,,,"Toxicity in syrian golden hamster infected with 10'2 CCID50 Yellow fever virus assessed as weight change in surviving animals at 400 mg/kg/day, po BID administered for 8 days started 4 days post viral challenge",Other,18955536.0,
335,543895,1,3,,103512718,492405,Unspecified,,,,,"Toxicity in syrian golden hamster infected with 10'2 CCID50 Yellow fever virus assessed as weight change in surviving animals at 400 mg/kg/day, po BID administered for 8 days started 5 days post viral challenge",Other,18955536.0,
336,543896,1,3,,103512718,492405,Unspecified,,,,,"Toxicity in syrian golden hamster infected with 10'2 CCID50 Yellow fever virus assessed as weight change in non surviving animals at 400 mg/kg/day, po BID administered for 8 days started 4 days post viral challenge",Other,18955536.0,
337,543897,1,3,,103512718,492405,Unspecified,,,,,"Toxicity in syrian golden hamster infected with 10'2 CCID50 Yellow fever virus assessed as weight change in non surviving animals at 400 mg/kg/day, po BID administered for 8 days started 5 days post viral challenge",Other,18955536.0,
338,543898,1,3,,103512718,492405,Unspecified,,,,,"Toxicity in syrian golden hamster infected with 10'2 CCID50 Yellow fever virus Jimenez assessed as weight change at 400 mg/kg/day, po administered twice daily for 8 days started 2 day post viral infection",Other,18955536.0,
339,543899,1,3,,103512718,492405,Unspecified,,,,,"Toxicity in syrian golden hamster infected with 10'2 CCID50 Yellow fever virus Jimenez assessed as weight change at 400 mg/kg/day, po administered twice daily for 8 days started 3 day post viral infection",Other,18955536.0,
340,543900,1,3,,103512718,492405,Unspecified,,,,,"Toxicity in syrian golden hamster infected with 10'2 CCID50 Yellow fever virus Jimenez assessed as weight change at 400 mg/kg/day, po administered twice daily for 8 days started 4 day post viral infection",Other,18955536.0,
341,543901,1,3,,103512718,492405,Unspecified,,,,,"Toxicity in syrian golden hamster infected with 10'2 CCID50 Yellow fever virus Jimenez assessed as weight change at 400 mg/kg/day, po administered twice daily for 8 days started 5 day post viral infection",Other,18955536.0,
342,543902,2,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against 10'2 CCID50 Yellow fever virus Jimenez infected in syrian golden hamster assessed as mean day of death of mice at 400 mg/kg/day, po administered twice daily for 8 days started 1 day post infection",Other,18955536.0,
343,543903,2,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against 10'2 CCID50 Yellow fever virus Jimenez infected in syrian golden hamster assessed as mean day of death of mice at 400 mg/kg/day, po administered twice daily for 8 days started 2 day post infection",Other,18955536.0,
344,543904,2,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against 10'2 CCID50 Yellow fever virus Jimenez infected in syrian golden hamster assessed as mean day of death of mice at 400 mg/kg/day, po administered twice daily for 8 days started 3 day post infection",Other,18955536.0,
345,543905,2,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against 10'2 CCID50 Yellow fever virus Jimenez infected in syrian golden hamster assessed as mean day of death of mice at 400 mg/kg/day, po administered twice daily for 8 days started 4 day post infection",Other,18955536.0,
346,543906,2,3,,103512718,492405,Unspecified,,,,,"Antiviral activity against 10'2 CCID50 Yellow fever virus Jimenez infected in syrian golden hamster assessed as mean day of death of mice at 400 mg/kg/day, po administered twice daily for 8 days started 5 day post infection",Other,18955536.0,
347,543907,2,3,,103512718,492405,Active,,,,,"Antiviral activity against 10'2 CCID50 Yellow fever virus Jimenez infected in syrian golden hamster assessed as survival of animal at 400 mg/kg/day, po administered twice daily for 8 days started 1 day post viral infection",Other,18955536.0,
348,543908,2,3,,103512718,492405,Active,,,,,"Antiviral activity against 10'2 CCID50 Yellow fever virus Jimenez infected in syrian golden hamster assessed as survival of animal at 400 mg/kg/day, po administered twice daily for 8 days started 2 day post viral infection",Other,18955536.0,
349,575124,4,4,,103512718,492405,Active,,,1.46,EC50,"Antiviral activity against adamantane-, oseltamivir-, zanamivir-susceptible Influenza A virus (A/Georgia/17/2006(H1N1)) infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain",Confirmatory,20350949.0,
350,575125,4,4,,103512718,492405,Active,,,2.55,EC50,"Antiviral activity against adamantane-, zanamivir-susceptible oseltamivir-resistant Influenza A virus (A/Georgia/20/2006(H1N1)) harboring neuraminidase H274Y mutant infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain",Confirmatory,20350949.0,
351,575126,4,4,,103512718,492405,Active,,,3.63,EC50,"Antiviral activity against adamantane-, oseltamivir-, zanamivir-susceptible Influenza A virus (A/California/27/2007(H1N1)) infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain",Confirmatory,20350949.0,
352,575127,4,4,,103512718,492405,Active,,,4.9,EC50,"Antiviral activity against adamantane-, zanamivir-susceptible oseltamivir-resistant Influenza A virus (A/New Jersey/15/2007(H1N1)) harboring neuraminidase H274Y mutant infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain",Confirmatory,20350949.0,
353,575230,4,2,,103512718,492405,Active,,,2.48,EC50,"Antiviral activity against adamantane-, oseltamivir-, zanamivir-susceptible Influenza A virus (A/Ecuador/5179/2008(H1N1)) infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain",Confirmatory,20350949.0,
354,575231,4,2,,103512718,492405,Active,,,4.7,EC50,"Antiviral activity against adamantane-susceptible zanamivir-, oseltamivir-resistant Influenza A virus (A/Santiago/5248/2008(H1N1)) harboring neuraminidase D198E mutant infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain",Confirmatory,20350949.0,
355,575232,4,2,,103512718,492405,Active,,,1.85,EC50,"Antiviral activity against adamantane-, oseltamivir-, zanamivir-susceptible Influenza A virus (A/Brazil/1067/2008(H1N1)) infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain",Confirmatory,20350949.0,
356,575233,4,2,,103512718,492405,Active,,,0.83,EC50,"Antiviral activity against adamantane-susceptible zanamivir-, oseltamivir-resistant Influenza A virus (A/Brazil/1633/2008(H1N1)) harboring neuraminidase Q136K mutant infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain",Confirmatory,20350949.0,
357,575234,4,2,,103512718,492405,Active,,,2.93,EC50,"Antiviral activity against oseltamivir-susceptible zanamivir-, adamantane-resistant Influenza A virus (A/Luhansk/18/2008(H1N1)) harboring neuraminidase H274Y mutant and M2 G34E mutant infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain",Confirmatory,20350949.0,
358,575235,4,2,,103512718,492405,Active,,,0.19,EC50,"Antiviral activity against adamantane-resistant zanamivir-,oseltamivir-susceptible Influenza A virus (A/New York/34/2008(H1N1)) harboring M2 L26I mutant infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain",Confirmatory,20350949.0,
359,575236,4,4,,103512718,492405,Active,,,3.25,EC50,"Antiviral activity against adamantane-, zanamivir-susceptible oseltamivir-resistant Influenza A virus (A/Washington/10/2008(H1N1)) harboring M2 S31N mutant infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain",Confirmatory,20350949.0,
360,575237,4,4,,103512718,492405,Active,,,1.59,EC50,"Antiviral activity against adamantane-, zanamivir-susceptible oseltamivir-resistant Influenza A virus (A/Florida/21/2008(H1N1)) harboring neuraminidase H274Y mutant infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain",Confirmatory,20350949.0,
361,575238,4,4,,103512718,492405,Active,,,2.87,EC50,"Antiviral activity against adamantane-resistant zanamivir-,oseltamivir-susceptible Influenza A virus (A/Wisconsin/16/2008(H1N1)) harboring neuraminidase H274Y mutant infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain",Confirmatory,20350949.0,
362,575239,4,4,,103512718,492405,Active,,,5.03,EC50,"Antiviral activity against adamantane-, zanamivir-susceptible oseltamivir-resistant Influenza A virus (A/North Carolina/02/ 2009(H1N1)) harboring M2 S31N mutant infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain",Confirmatory,20350949.0,
363,575240,4,4,,103512718,492405,Active,,,2.93,EC50,"Antiviral activity against adamantane-, oseltamivir-, zanamivir-resistant Influenza A virus (A/Idaho/01/2009(H1N1)) harboring neuraminidase H274Y mutant infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain",Confirmatory,20350949.0,
364,575241,4,2,,103512718,492405,Active,,,5.99,EC50,"Antiviral activity against adamantane-resistant zanamivir-,oseltamivir-susceptible Influenza A virus (A/Wuhan/395/1995-like (H3N2)) infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain",Confirmatory,20350949.0,
365,575242,4,2,,103512718,492405,Active,,,5.41,EC50,"Antiviral activity against oseltamivir-susceptible zanamivir-, adamantane-resistant Influenza A virus (A/Wuhan/395/1995-like (H3N2)) harboring neuraminidase E119V mutant infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain",Confirmatory,20350949.0,
366,575243,4,4,,103512718,492405,Active,,,1.21,EC50,"Antiviral activity against oseltamivir-susceptible zanamivir-, adamantane-resistant Influenza A virus (A/Bethesda/956/2006(H3N2)) harboring neuraminidase R292K mutant and M2 S31N mutant infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain",Confirmatory,20350949.0,
367,575244,4,4,,103512718,492405,Active,,,4.46,EC50,"Antiviral activity against adamantane-resistant zanamivir-,oseltamivir-susceptible Influenza A virus (A/Washington/01/2007(H3N2)) harboring M2 S31N mutant infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain",Confirmatory,20350949.0,
368,575245,4,4,,103512718,492405,Active,,,3.95,EC50,"Antiviral activity against oseltamivir-susceptible zanamivir-, adamantane-resistant Influenza A virus (A/Texas/12/2007 (clone)(H3N2)) harboring neuraminidase E119I mutant and harboring M2 S31N mutant infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain",Confirmatory,20350949.0,
369,575246,4,4,,103512718,492405,Active,,,5.22,EC50,"Antiviral activity against oseltamivir-susceptible zanamivir-, adamantane-resistant Influenza A virus (A/Texas/12/2007 (clone)(H3N2)) harboring neuraminidase E119V mutant and harboring M2 S31N mutant infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain",Confirmatory,20350949.0,
370,575247,4,4,,103512718,492405,Active,,,0.45,EC50,"Antiviral activity against adamantane-resistant zanamivir-,oseltamivir-susceptible Influenza A virus (A/Florida/01/2009(H3N2)) harboring M2 S31N mutant infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain",Confirmatory,20350949.0,
371,575248,4,4,,103512718,492405,Active,,,4.08,EC50,"Antiviral activity against adamantane-resistant zanamivir-,oseltamivir-susceptible Influenza A virus (A/New Hampshire/01/2009(H3N2)) harboring M2 S31N mutant infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain",Confirmatory,20350949.0,
372,575249,4,2,,103512718,492405,Active,,,4.2,EC50,"Antiviral activity against adamantane-resistant zanamivir-,oseltamivir-susceptible Influenza A virus (A/Massachusetts/03/2009(H3N2)) harboring M2 S31N mutant infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain",Confirmatory,20350949.0,
373,575250,4,2,,103512718,492405,Active,,,1.21,EC50,"Antiviral activity against adamantane-resistant zanamivir-,oseltamivir-susceptible Influenza B virus B/Memphis/20/1996 infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain",Confirmatory,20350949.0,
374,575251,4,2,,103512718,492405,Active,,,0.57,EC50,"Antiviral activity against oseltamivir-susceptible zanamivir-, adamantane-resistant Influenza B virus B/Memphis/20/1996 harboring neuraminidase R152K mutant infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain",Confirmatory,20350949.0,
375,575252,4,2,,103512718,492405,Active,,,1.4,EC50,"Antiviral activity against adamantane-resistant zanamivir-,oseltamivir-susceptible Influenza B virus (B/Rochester/01/2001) infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain",Confirmatory,20350949.0,
376,575253,4,2,,103512718,492405,Active,,,1.72,EC50,"Antiviral activity against oseltamivir-susceptible zanamivir-, adamantane-resistant Influenza B virus (B/Rochester/01/2001) harboring neuraminidase D198N mutant infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain",Confirmatory,20350949.0,
377,575254,4,2,,103512718,492405,Active,,,5.3,EC50,"Antiviral activity against adamantane-resistant zanamivir-,oseltamivir-susceptible Influenza B virus (B/New York/22/2008) infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain",Confirmatory,20350949.0,
378,575255,4,2,,103512718,492405,Active,,,3.0,EC50,"Antiviral activity against adamantane-, oseltamivir-, zanamivir-resistant Influenza B virus (B/Illinois/03/2008) harboring neuraminidase E119A mutant infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain",Confirmatory,20350949.0,
379,575256,4,2,,103512718,492405,Active,,,4.01,EC50,"Antiviral activity against adamantane-resistant zanamivir-,oseltamivir-susceptible Influenza B virus (B/Illinois/47/2005) infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain",Confirmatory,20350949.0,
380,575257,4,2,,103512718,492405,Active,,,5.03,EC50,"Antiviral activity against oseltamivir-susceptible zanamivir-, adamantane-resistant Influenza B virus (B/Michigan/20/2005) harboring neuraminidase H274Y mutant infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain",Confirmatory,20350949.0,
381,575258,4,2,,103512718,492405,Active,,,0.83,EC50,"Antiviral activity against adamantane-, oseltamivir-, zanamivir-susceptible Influenza A virus (A/Swine/South Dakota/03/2008(H1N1)) infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain",Confirmatory,20350949.0,
382,575259,4,2,,103512718,492405,Active,,,4.52,EC50,"Antiviral activity against adamantane-, oseltamivir-, zanamivir-susceptible Influenza A virus (A/Swine/Texas/14/2008 (H1N1)) harboring M2 V27T, V28D mutant infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain",Confirmatory,20350949.0,
383,575260,4,4,,103512718,492405,Active,,,2.23,EC50,"Antiviral activity against adamantane-, oseltamivir-, zanamivir-susceptible Influenza A virus (A/swine/Michigan/09/2007 (H1N2)) harboring M2 V27I, V28D mutant infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain",Confirmatory,20350949.0,
384,575261,4,4,,103512718,492405,Active,,,1.21,EC50,"Antiviral activity against adamantane-resistant zanamivir-,oseltamivir-susceptible Influenza A virus (A/pdm/Mexico/4604/2009 (H1N1)) harboring M2 V28I, S31N mutant infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain",Confirmatory,20350949.0,
385,575262,4,4,,103512718,492405,Active,,,1.97,EC50,"Antiviral activity against adamantane-resistant zanamivir-,oseltamivir-susceptible Influenza A virus (A/pdm/California/04/2009 (H1N1)) harboring M2 V28I, S31N mutant infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain",Confirmatory,20350949.0,
386,575263,4,4,,103512718,492405,Active,,,0.83,EC50,"Antiviral activity against adamantane-resistant zanamivir-,oseltamivir-susceptible Influenza A virus (A/pdm/California/05/2009 (H1N1)) harboring M2 V28I, S31N mutant infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain",Confirmatory,20350949.0,
387,575378,4,4,,103512718,492405,Active,,,1.4,EC50,"Antiviral activity against adamantane-resistant zanamivir-,oseltamivir-susceptible Influenza A virus (A/pdm/California/07/2009 (H1N1)) harboring M2 V28I, S31N mutant infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain",Confirmatory,20350949.0,
388,575379,4,4,,103512718,492405,Active,,,0.89,EC50,"Antiviral activity against adamantane-resistant zanamivir-,oseltamivir-susceptible Influenza A virus (A/pdm/New York/18/2009 (H1N1)) harboring M2 V28I, S31N mutant infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain",Confirmatory,20350949.0,
389,575380,4,2,,103512718,492405,Active,,,22.48,EC50,"Antiviral activity against oseltamivir-susceptible zanamivir-, adamantane-resistant Influenza A virus (A/pdm/Illinois/10/2009(H1N1)) harboring M2 V28I, S31N mutant and neuraminidase H274Y mutant infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain",Confirmatory,20350949.0,
390,575381,4,4,,103512718,492405,Active,,,6.62,EC50,"Antiviral activity against oseltamivir-susceptible zanamivir-, adamantane-resistant Influenza A virus (A/pdm/Washington/29/2009 (H1N1)) harboring M2 V28I, S31N mutant and neuraminidase H274Y mutant infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain",Confirmatory,20350949.0,
391,575382,4,4,,103512718,492405,Active,,,0.38,EC50,"Antiviral activity against adamantane-, oseltamivir-, zanamivir-susceptible Influenza A virus (A/Ann Arbor/6/1960(H2N2)) infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain",Confirmatory,20350949.0,
392,575383,4,4,,103512718,492405,Active,,,0.96,EC50,"Antiviral activity against adamantane-, oseltamivir-, zanamivir-susceptible Influenza A virus (A/turkey/Minnesota/833/1980(H4N2)) infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain",Confirmatory,20350949.0,
393,575384,4,4,,103512718,492405,Active,,,0.89,EC50,"Antiviral activity against adamantane-, zanamivir-susceptible oseltamivir-resistant Influenza A virus (A/turkey/Minnesota/833/1980(H4N2)) harboring neuraminidase E119G mutant infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain",Confirmatory,20350949.0,
394,575385,4,2,,103512718,492405,Active,,,1.59,EC50,"Antiviral activity against adamantane-, oseltamivir-, zanamivir-susceptible Influenza A virus (A/duck/Vietnam/NCVD93/2007 clade 2.3.4 (H5N1)) infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain",Confirmatory,20350949.0,
395,575386,4,2,,103512718,492405,Active,,,3.38,EC50,"Antiviral activity against adamantane-susceptible zanamivir-, oseltamivir-resistant Influenza A virus (A/duck/Vietnam/NCVD94/2007 clade 2.3.4 (H5N1)) harboring neuraminidase I117V mutant infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain",Confirmatory,20350949.0,
396,575387,4,2,,103512718,492405,Active,,,1.27,EC50,"Antiviral activity against adamantane-, oseltamivir-, zanamivir-susceptible Influenza A virus (A/chicken/Vietnam/NCVD103/2007 clade 2.3.4 (H5N1)) harboring neuraminidase I222T mutant infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain",Confirmatory,20350949.0,
397,575388,4,2,,103512718,492405,Active,,,5.22,EC50,"Antiviral activity against adamantane-resistant zanamivir-,oseltamivir-susceptible Influenza A virus (A/Vietnam/1203/2004 clade 1 (H5N1)) harboring M2 L26I, S31N mutant infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain",Confirmatory,20350949.0,
398,575389,4,2,,103512718,492405,Active,,,4.14,EC50,"Antiviral activity against oseltamivir-susceptible zanamivir-, adamantane-resistant Influenza A virus (A/Vietnam/HN30408/2005 H274Y clade 1 (H5N1)) harboring M2 L26I, S31N mutant and neuraminidase H274Y mutant infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain",Confirmatory,20350949.0,
399,575390,4,2,,103512718,492405,Active,,,1.341,EC50,"Antiviral activity against adamantane-, oseltamivir-, zanamivir-resistant Influenza A virus (A/Vietnam/HN30408/2005 N294S clade 1 (H5N1)) harboring M2 L26I, S31N mutant and neuraminidase N294S mutant infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain",Confirmatory,20350949.0,
400,575391,4,2,,103512718,492405,Active,,,1.53,EC50,"Antiviral activity against adamantane-, oseltamivir-, zanamivir-susceptible Influenza A virus (A/turkey/VA/4529/2002 (H7N2)) infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain",Confirmatory,20350949.0,
401,575392,4,4,,103512718,492405,Active,,,10.2,EC50,"Antiviral activity against adamantane-resistant zanamivir-,oseltamivir-susceptible Influenza A virus (A/New York/107/2003(H7N2)) harboring M2 V28A, S31N mutant infected in MDCK cells assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain",Confirmatory,20350949.0,
402,575393,2,6,,103512718,492405,Active,,,,,"Antiviral activity against adamantane-resistant zanamivir-,oseltamivir-susceptible Influenza A virus (A/pdm/Mexico/4604/2009(H1N1)) harboring M2 V28I, S31N mutant infected in MDCK cells assessed as determination of viral titer in cell culture at 128 uM after 24 hrs by immunofluorescence assay",Other,20350949.0,
403,575394,2,6,,103512718,492405,Active,,,,,"Antiviral activity against adamantane-resistant zanamivir-,oseltamivir-susceptible Influenza A virus (A/pdm/California/04/2009(H1N1)) harboring M2 V28I, S31N mutant infected in MDCK cells assessed as determination of viral titer in cell culture at 128 uM after 24 hrs by immunofluorescence assay",Other,20350949.0,
404,575395,2,6,,103512718,492405,Active,,,,,"Antiviral activity against 0.001 MOI adamantane-resistant zanamivir-,oseltamivir-susceptible Influenza A virus (A/pdm/Mexico/4604/2009(H1N1)) harboring M2 V28I, S31N mutant infected in MDCK cells assessed as determination of viral titer in cell culture at 1.6 uM after 24 hrs by immunofluorescence assay",Other,20350949.0,
405,575396,2,6,,103512718,492405,Active,,,,,"Antiviral activity against 0.001 MOI adamantane-resistant zanamivir-,oseltamivir-susceptible Influenza A virus (A/pdm/California/04/2009(H1N1)) harboring M2 V28I, S31N mutant infected in MDCK cells assessed as determination of viral titer in cell culture at 1.6 uM after 24 hrs by immunofluorescence assay",Other,20350949.0,
406,575397,2,6,,103512718,492405,Unspecified,,,,,Antiviral activity against Influenza A virus (A/California/04/2009(H1N1)) infected in MDCK cells from ATCC assessed as log reduction in viral titer at 1.6 uM after 24 hrs by immunofluorescent assay,Other,20350949.0,
407,575398,2,6,,103512718,492405,Unspecified,,,,,Antiviral activity against Influenza A virus (A/Mexico/4604/2009(H1N1)) infected in MDCK cells from ATCC assessed as log reduction in viral titer at 1.6 uM after 24 hrs by immunofluorescent assay,Other,20350949.0,
408,575399,2,6,,103512718,492405,Unspecified,,,,,Antiviral activity against Influenza A virus (A/Washington/29/2009(H1N1)) harboring neuraminidase H275Y mutant infected in MDCK cells from ATCC assessed as log reduction in viral titer at 1.6 uM after 24 hrs by immunofluorescent assay,Other,20350949.0,
409,575400,2,4,,103512718,492405,Unspecified,,,,,Antiviral activity against Influenza A virus (A/Illinois/10/2009(H1N1)) harboring neuraminidase H275Y mutant infected in MDCK cells from ATCC assessed as log reduction in viral titer at 1.6 uM after 24 hrs by immunofluorescent assay,Other,20350949.0,
410,575401,2,6,,103512718,492405,Unspecified,,,,,Antiviral activity against Influenza A virus (A/California/04/2009(H1N1)) infected in MDCK cells from Mill Hill assessed as log reduction in viral titer at 1.6 uM after 24 hrs by immunofluorescent assay,Other,20350949.0,
411,575402,2,6,,103512718,492405,Unspecified,,,,,Antiviral activity against Influenza A virus (A/Mexico/4604/2009(H1N1)) infected in MDCK cells from Mill Hill assessed as log reduction in viral titer at 1.6 uM after 24 hrs by immunofluorescent assay,Other,20350949.0,
412,575403,2,6,,103512718,492405,Unspecified,,,,,Antiviral activity against Influenza A virus (A/Washington/29/2009(H1N1)) harboring neuraminidase H275Y mutant infected in MDCK cells from Mill Hill assessed as log reduction in viral titer at 1.6 uM after 24 hrs by immunofluorescent assay,Other,20350949.0,
413,575404,2,4,,103512718,492405,Unspecified,,,,,Antiviral activity against Influenza A virus (A/Illinois/10/2009(H1N1)) harboring neuraminidase H275Y mutant infected in MDCK cells from Mill Hill assessed as log reduction in viral titer at 1.6 uM after 24 hrs by immunofluorescent assay,Other,20350949.0,
414,575405,2,6,,103512718,492405,Unspecified,,,,,Antiviral activity against sInfluenza A virus (A/California/04/2009(H1N1)) infected in MDCK cells from ATCC assessed as log reduction in viral titer at 4.7 uM after 24 hrs by immunofluorescent assay,Other,20350949.0,
415,575406,2,6,,103512718,492405,Unspecified,,,,,Antiviral activity against Influenza A virus (A/Mexico/4604/2009(H1N1)) infected in MDCK cells from ATCC assessed as log reduction in viral titer at 4.7 uM after 24 hrs by immunofluorescent assay,Other,20350949.0,
416,575407,2,6,,103512718,492405,Unspecified,,,,,Antiviral activity against sInfluenza A virus (A/Washington/29/2009(H1N1)) infected in MDCK cells from ATCC assessed as log reduction in viral titer at 4.7 uM after 24 hrs by immunofluorescent assay,Other,20350949.0,
417,575408,2,4,,103512718,492405,Unspecified,,,,,Antiviral activity against Influenza A virus (A/Illinois/10/2009(H1N1)) infected in MDCK cells from ATCC assessed as log reduction in viral titer at 4.7 uM after 24 hrs by immunofluorescent assay,Other,20350949.0,
418,575409,2,6,,103512718,492405,Unspecified,,,,,Antiviral activity against sInfluenza A virus (A/California/04/2009(H1N1)) infected in MDCK cells from Mill Hill assessed as log reduction in viral titer at 4.7 uM after 24 hrs by immunofluorescent assay,Other,20350949.0,
419,575410,2,6,,103512718,492405,Unspecified,,,,,Antiviral activity against Influenza A virus (A/Mexico/4604/2009(H1N1))infected in MDCK cells from Mill Hill assessed as log reduction in viral titer at 4.7 uM after 24 hrs by immunofluorescent assay,Other,20350949.0,
420,575411,2,6,,103512718,492405,Unspecified,,,,,Antiviral activity against sInfluenza A virus (A/Washington/29/2009(H1N1)) infected in MDCK cells from Mill Hill assessed as log reduction in viral titer at 4.7 uM after 24 hrs by immunofluorescent assay,Other,20350949.0,
421,575412,2,4,,103512718,492405,Unspecified,,,,,Antiviral activity against Influenza A virus (A/Illinois/10/2009(H1N1)) infected in MDCK cells from Mill Hill assessed as log reduction in viral titer at 4.7 uM after 24 hrs by immunofluorescent assay,Other,20350949.0,
422,575413,2,6,,103512718,492405,Unspecified,,,,,Antiviral activity against sInfluenza A virus (A/California/04/2009(H1N1))infected in MDCK cells from ATCC assessed as log reduction in viral titer at 14.2 uM after 24 hrs by immunofluorescent assay,Other,20350949.0,
423,575511,2,6,,103512718,492405,Unspecified,,,,,Antiviral activity against Influenza A virus (A/Mexico/4604/2009(H1N1)) infected in MDCK cells from ATCC assessed as log reduction in viral titer at 14.2 uM after 24 hrs by immunofluorescent assay,Other,20350949.0,
424,575512,2,6,,103512718,492405,Unspecified,,,,,Antiviral activity against sInfluenza A virus (A/Washington/29/2009(H1N1)) infected in MDCK cells from ATCC assessed as log reduction in viral titer at 14.2 uM after 24 hrs by immunofluorescent assay,Other,20350949.0,
425,575513,2,4,,103512718,492405,Unspecified,,,,,Antiviral activity against Influenza A virus (A/Illinois/10/2009(H1N1)) infected in MDCK cells from ATCC assessed as log reduction in viral titer at 14.2 uM after 24 hrs by immunofluorescent assay,Other,20350949.0,
426,575514,2,6,,103512718,492405,Unspecified,,,,,Antiviral activity against sInfluenza A virus (A/California/04/2009(H1N1)) infected in MDCK cells from Mill Hill assessed as log reduction in viral titer at 14.2 uM after 24 hrs by immunofluorescent assay,Other,20350949.0,
427,575515,2,6,,103512718,492405,Unspecified,,,,,Antiviral activity against Influenza A virus (A/Mexico/4604/2009(H1N1)) infected in MDCK cells from Mill Hill assessed as log reduction in viral titer at 14.2 uM after 24 hrs by immunofluorescent assay,Other,20350949.0,
428,575516,2,6,,103512718,492405,Unspecified,,,,,Antiviral activity against sInfluenza A virus (A/Washington/29/2009(H1N1))) infected in MDCK cells from Mill Hill assessed as log reduction in viral titer at 14.2 uM after 24 hrs by immunofluorescent assay,Other,20350949.0,
429,575517,2,4,,103512718,492405,Unspecified,,,,,Antiviral activity against Influenza A virus (A/Illinois/10/2009(H1N1)) infected in MDCK cells from Mill Hill assessed as log reduction in viral titer at 14.2 uM after 24 hrs by immunofluorescent assay,Other,20350949.0,
430,575518,2,6,,103512718,492405,Unspecified,,,,,Antiviral activity against sInfluenza A virus (A/California/04/2009(H1N1)) infected in MDCK cells from ATCC assessed as log reduction in viral titer at 42.7 uM after 24 hrs by immunofluorescent assay,Other,20350949.0,
431,575519,2,6,,103512718,492405,Unspecified,,,,,Antiviral activity against Influenza A virus (A/Mexico/4604/2009(H1N1)) infected in MDCK cells from ATCC assessed as log reduction in viral titer at 42.7 uM after 24 hrs by immunofluorescent assay,Other,20350949.0,
432,575520,2,6,,103512718,492405,Unspecified,,,,,Antiviral activity against sInfluenza A virus (A/Washington/29/2009(H1N1)) infected in MDCK cells from ATCC assessed as log reduction in viral titer at 42.7 uM after 24 hrs by immunofluorescent assay,Other,20350949.0,
433,575521,2,4,,103512718,492405,Unspecified,,,,,Antiviral activity against Influenza A virus (A/Illinois/10/2009(H1N1)) infected in MDCK cells from ATCC assessed as log reduction in viral titer at 42.7 uM after 24 hrs by immunofluorescent assay,Other,20350949.0,
434,575522,2,6,,103512718,492405,Unspecified,,,,,Antiviral activity against sInfluenza A virus (A/California/04/2009(H1N1)) infected in MDCK cells from Mill Hill assessed as log reduction in viral titer at 42.7 uM after 24 hrs by immunofluorescent assay,Other,20350949.0,
435,575523,2,6,,103512718,492405,Unspecified,,,,,Antiviral activity against Influenza A virus (A/Mexico/4604/2009(H1N1)) infected in MDCK cells from Mill Hill assessed as log reduction in viral titer at 42.7 uM after 24 hrs by immunofluorescent assay,Other,20350949.0,
436,575524,2,6,,103512718,492405,Unspecified,,,,,Antiviral activity against sInfluenza A virus (A/Washington/29/2009(H1N1)) infected in MDCK cells from Mill Hill assessed as log reduction in viral titer at 42.7 uM after 24 hrs by immunofluorescent assay,Other,20350949.0,
437,575525,2,4,,103512718,492405,Unspecified,,,,,Antiviral activity against Influenza A virus (A/Illinois/10/2009(H1N1)) infected in MDCK cells from Mill Hill assessed as log reduction in viral titer at 42.7 uM after 24 hrs by immunofluorescent assay,Other,20350949.0,
438,575526,2,6,,103512718,492405,Unspecified,,,,,Antiviral activity against sInfluenza A virus (A/California/04/2009(H1N1)) infected in MDCK cells from ATCC assessed as log reduction in viral titer at 128 uM after 24 hrs by immunofluorescent assay,Other,20350949.0,
439,575527,2,6,,103512718,492405,Unspecified,,,,,Antiviral activity against Influenza A virus (A/Mexico/4604/2009(H1N1)) infected in MDCK cells from ATCC assessed as log reduction in viral titer at 128 uM after 24 hrs by immunofluorescent assay,Other,20350949.0,
440,575528,2,6,,103512718,492405,Unspecified,,,,,Antiviral activity against sInfluenza A virus (A/Washington/29/2009(H1N1)) infected in MDCK cells from ATCC assessed as log reduction in viral titer at 128 uM after 24 hrs by immunofluorescent assay,Other,20350949.0,
441,575529,2,4,,103512718,492405,Unspecified,,,,,Antiviral activity against Influenza A virus (A/Illinois/10/2009(H1N1)) infected in MDCK cells from ATCC assessed as log reduction in viral titer at 128 uM after 24 hrs by immunofluorescent assay,Other,20350949.0,
442,575530,2,6,,103512718,492405,Unspecified,,,,,Antiviral activity against Influenza A virus (A/California/04/2009(H1N1)) infected in MDCK cells from Mill Hill assessed as log reduction in viral titer at 128 uM after 24 hrs by immunofluorescent assay,Other,20350949.0,
443,575531,2,6,,103512718,492405,Unspecified,,,,,Antiviral activity against Influenza A virus (A/Mexico/4604/2009(H1N1)) infected in MDCK cells from Mill Hill assessed as log reduction in viral titer at 128 uM after 24 hrs by immunofluorescent assay,Other,20350949.0,
444,575532,2,6,,103512718,492405,Unspecified,,,,,Antiviral activity against Influenza A virus (A/Washington/29/2009(H1N1)) infected in MDCK cells from Mill Hill assessed as log reduction in viral titer at 128 uM after 24 hrs by immunofluorescent assay,Other,20350949.0,
445,575533,2,4,,103512718,492405,Unspecified,,,,,Antiviral activity against Influenza A virus (A/Illinois/10/2009(H1N1)) infected in MDCK cells from Mill Hill assessed as log reduction in viral titer at 128 uM after 24 hrs by immunofluorescent assay,Other,20350949.0,
446,575534,2,6,,103512718,492405,Unspecified,,,,,Antiviral activity against Influenza A virus (A/California/04/2009(H1N1)) infected in MDCK cells from ATCC assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain,Other,20350949.0,
447,575535,2,6,,103512718,492405,Unspecified,,,,,Antiviral activity against Influenza A virus (A/Mexico/4604/2009(H1N1)) infected in MDCK cells from ATCC assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain,Other,20350949.0,
448,575536,2,6,,103512718,492405,Unspecified,,,,,Antiviral activity against Influenza A virus (A/Washington/29/2009(H1N1)) harboring neuraminidase H275Y mutant infected in MDCK cells from ATCC assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain,Other,20350949.0,
449,575537,2,4,,103512718,492405,Unspecified,,,,,Antiviral activity against Influenza A virus (A/Illinois/10/2009(H1N1)) harboring neuraminidase H275Y mutant infected in MDCK cells from ATCC assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain,Other,20350949.0,
450,575538,2,6,,103512718,492405,Unspecified,,,,,Antiviral activity against Influenza A virus (A/California/04/2009(H1N1)) infected in MDCK cells from Mill Hill assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain,Other,20350949.0,
451,575539,2,6,,103512718,492405,Unspecified,,,,,Antiviral activity against Influenza A virus (A/Mexico/4604/2009(H1N1)) infected in MDCK cells from Mill Hill assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain,Other,20350949.0,
452,575540,2,6,,103512718,492405,Unspecified,,,,,Antiviral activity against Influenza A virus (A/Washington/29/2009(H1N1)) harboring neuraminidase H275Y mutant infected in MDCK cells from Mill Hill assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain,Other,20350949.0,
453,575541,2,4,,103512718,492405,Unspecified,,,,,Antiviral activity against Influenza A virus (A/Illinois/10/2009(H1N1)) harboring neuraminidase H275Y mutant infected in MDCK cells from Mill Hill assessed as inhibition of viral replication after 3 days by microscopic analysis using crystal violet stain,Other,20350949.0,
454,733264,1,2,,103512718,492405,Active,,,1.32,EC50,Antiviral activity against Influenza B virus (B/Brisbane/60/2008) infected in MDCK cells assessed as inhibition of virus-induced cytopathogenicity at 1 hr post-infection measured after 3 days by fluorescein-diacetate based fluorimetric analysis,Confirmatory,23419738.0,
455,733265,1,2,,103512718,492405,Active,,,1.93,EC50,Antiviral activity against Influenza B virus (B/Lee/40) infected in MDCK cells assessed as inhibition of virus-induced cytopathogenicity at 1 hr post-infection measured after 3 days by fluorescein-diacetate based fluorimetric analysis,Confirmatory,23419738.0,
456,733266,1,3,,103512718,492405,Active,,,2.84,EC50,Antiviral activity against Influenza B virus (B/Taiwan/2/62) infected in MDCK cells assessed as inhibition of virus-induced cytopathogenicity at 1 hr post-infection measured after 3 days by fluorescein-diacetate based fluorimetric analysis,Confirmatory,23419738.0,
457,733267,1,2,,103512718,492405,Active,,,1.94,EC50,Antiviral activity against Influenza B virus (B/Panama/45/1990) infected in MDCK cells assessed as inhibition of virus-induced cytopathogenicity at 1 hr post-infection measured after 3 days by fluorescein-diacetate based fluorimetric analysis,Confirmatory,23419738.0,
458,733268,1,3,,103512718,492405,Active,,,4.71,EC50,Antiviral activity against Influenza A virus (A/Hong kong/8/1968(H2N3)) infected in MDCK cells assessed as inhibition of virus-induced cytopathogenicity at 1 hr post-infection measured after 3 days by fluorescein-diacetate based fluorimetric analysis,Confirmatory,23419738.0,
459,733269,1,4,,103512718,492405,Active,,,6.95,EC50,Antiviral activity against Influenza A virus (A/Taiwan/1/1986(H1N1)) infected in MDCK cells assessed as inhibition of virus-induced cytopathogenicity at 1 hr post-infection measured after 3 days by fluorescein-diacetate based fluorimetric analysis,Confirmatory,23419738.0,
460,733270,1,2,,103512718,492405,Unspecified,,,100.0,CC50,Cytotoxicity against MDCK cells after 3 days by fluorescein diacetate-based fluorimetric analysis,Confirmatory,23419738.0,
461,1159620,1,1,,103512718,492405,Active,,,,,Summary of drug indications.,Other,,
462,1259416,1,2,,340085400,492405,Inactive,56786138.0,3458.0,,,Toxoplasma gondii inhibition HTS in the presence of IFN-y,Screening,,
463,1259421,1,1,,340085400,492405,Inactive,56786138.0,3458.0,,,Toxoplasma gondii HTS in the absence of IFN-y,Screening,,
